<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T06:42:20Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4216374" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:4216374</identifier>
        <datestamp>2014-11-02</datestamp>
        <setSpec>bmcpm</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMC Pulm Med</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMC Pulm Med</journal-id>
              <journal-title-group>
                <journal-title>BMC Pulmonary Medicine</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1471-2466</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC4216374</article-id>
              <article-id pub-id-type="pmcid">PMC4216374</article-id>
              <article-id pub-id-type="pmc-uid">4216374</article-id>
              <article-id pub-id-type="pmid">25341556</article-id>
              <article-id pub-id-type="pmid">25341556</article-id>
              <article-id pub-id-type="publisher-id">599</article-id>
              <article-id pub-id-type="doi">10.1186/1471-2466-14-164</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Hersh</surname>
                    <given-names>Craig P</given-names>
                  </name>
                  <address>
                    <email>craig.hersh@channing.harvard.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1"/>
                  <xref ref-type="aff" rid="Aff2"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Make</surname>
                    <given-names>Barry J</given-names>
                  </name>
                  <address>
                    <email>makeb@njhealth.org</email>
                  </address>
                  <xref ref-type="aff" rid="Aff3"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lynch</surname>
                    <given-names>David A</given-names>
                  </name>
                  <address>
                    <email>lynchd@njhealth.org</email>
                  </address>
                  <xref ref-type="aff" rid="Aff4"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Barr</surname>
                    <given-names>R Graham</given-names>
                  </name>
                  <address>
                    <email>rgb9@columbia.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff5"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bowler</surname>
                    <given-names>Russell P</given-names>
                  </name>
                  <address>
                    <email>bowler@njhealth.org</email>
                  </address>
                  <xref ref-type="aff" rid="Aff3"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Calverley</surname>
                    <given-names>Peter MA</given-names>
                  </name>
                  <address>
                    <email>pmacal@liverpool.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff6"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Castaldi</surname>
                    <given-names>Peter J</given-names>
                  </name>
                  <address>
                    <email>peter.castaldi@channing.harvard.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cho</surname>
                    <given-names>Michael H</given-names>
                  </name>
                  <address>
                    <email>michael.cho@channing.harvard.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1"/>
                  <xref ref-type="aff" rid="Aff2"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Coxson</surname>
                    <given-names>Harvey O</given-names>
                  </name>
                  <address>
                    <email>Harvey.Coxson@vch.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff7"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>DeMeo</surname>
                    <given-names>Dawn L</given-names>
                  </name>
                  <address>
                    <email>dawn.demeo@channing.harvard.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1"/>
                  <xref ref-type="aff" rid="Aff2"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Foreman</surname>
                    <given-names>Marilyn G</given-names>
                  </name>
                  <address>
                    <email>mforeman@msm.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff8"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Han</surname>
                    <given-names>MeiLan K</given-names>
                  </name>
                  <address>
                    <email>mrking@umich.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff9"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Harshfield</surname>
                    <given-names>Benjamin J</given-names>
                  </name>
                  <address>
                    <email>benjamin.harshfield@channing.harvard.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hokanson</surname>
                    <given-names>John E</given-names>
                  </name>
                  <address>
                    <email>john.hokanson@ucdenver.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff10"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lutz</surname>
                    <given-names>Sharon</given-names>
                  </name>
                  <address>
                    <email>Sharon.lutz@ucdenver.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff11"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ramsdell</surname>
                    <given-names>Joe W</given-names>
                  </name>
                  <address>
                    <email>jramsdell@ucsd.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff12"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Regan</surname>
                    <given-names>Elizabeth A</given-names>
                  </name>
                  <address>
                    <email>regane@njhealth.org</email>
                  </address>
                  <xref ref-type="aff" rid="Aff3"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rennard</surname>
                    <given-names>Stephen I</given-names>
                  </name>
                  <address>
                    <email>srennard@unmc.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff13"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Schroeder</surname>
                    <given-names>Joyce D</given-names>
                  </name>
                  <address>
                    <email>schroederj@njhealth.org</email>
                  </address>
                  <xref ref-type="aff" rid="Aff4"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sciurba</surname>
                    <given-names>Frank C</given-names>
                  </name>
                  <address>
                    <email>sciurbafc@upmc.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff14"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Steiner</surname>
                    <given-names>Robert M</given-names>
                  </name>
                  <address>
                    <email>rsteiner5933@aol.com</email>
                  </address>
                  <xref ref-type="aff" rid="Aff15"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tal-Singer</surname>
                    <given-names>Ruth</given-names>
                  </name>
                  <address>
                    <email>Ruth.M.Tal-Singer@gsk.com</email>
                  </address>
                  <xref ref-type="aff" rid="Aff16"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>van Beek</surname>
                    <given-names>Edwin JR</given-names>
                  </name>
                  <address>
                    <email>edwin-vanbeek@ed.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff17"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Silverman</surname>
                    <given-names>Edwin K</given-names>
                  </name>
                  <address>
                    <email>ed.silverman@channing.harvard.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1"/>
                  <xref ref-type="aff" rid="Aff2"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Crapo</surname>
                    <given-names>James D</given-names>
                  </name>
                  <address>
                    <email>crapoj@njhealth.org</email>
                  </address>
                  <xref ref-type="aff" rid="Aff3"/>
                </contrib>
                <contrib contrib-type="author">
                  <collab>the COPDGene and ECLIPSE Investigators</collab>
                </contrib>
                <aff id="Aff1"><label/>Channing Division of Network Medicine, Boston, MA USA </aff>
                <aff id="Aff2"><label/>Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Boston, MA USA </aff>
                <aff id="Aff3"><label/>Division of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, CO USA </aff>
                <aff id="Aff4"><label/>Department of Radiology, National Jewish Health, Denver, CO USA </aff>
                <aff id="Aff5"><label/>Department of Medicine, Columbia University, New York, NY USA </aff>
                <aff id="Aff6"><label/>Division of Infection and Immunity Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK </aff>
                <aff id="Aff7"><label/>Department of Radiology, University of British Columbia, Vancouver, Canada </aff>
                <aff id="Aff8"><label/>Division of Pulmonary and Critical Care Medicine, Morehouse School of Medicine, Atlanta, GA USA </aff>
                <aff id="Aff9"><label/>Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, MI USA </aff>
                <aff id="Aff10"><label/>Department of Epidemiology, Colorado School of Public Health, Aurora, CO USA </aff>
                <aff id="Aff11"><label/>Department of Biostatistics, Colorado School of Public Health, Aurora, CO USA </aff>
                <aff id="Aff12"><label/>Division of Pulmonary and Critical Care Medicine, University of California, San Diego, CA USA </aff>
                <aff id="Aff13"><label/>Division of Pulmonary, Critical Care, Sleep and Allergy, University of Nebraska Medical Center, Omaha, NE USA </aff>
                <aff id="Aff14"><label/>Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA USA </aff>
                <aff id="Aff15"><label/>Department of Radiology, Temple University, Philadelphia, PA USA </aff>
                <aff id="Aff16"><label/>GlaxoSmithKline R&amp;D, King of Prussia, PA USA </aff>
                <aff id="Aff17"><label/>Department of Radiology, University of Edinburgh, Edinburgh, Scotland </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>24</day>
                <month>10</month>
                <year>2014</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>24</day>
                <month>10</month>
                <year>2014</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2014</year>
              </pub-date>
              <volume>14</volume>
              <elocation-id>164</elocation-id>
              <history>
                <date date-type="received">
                  <day>6</day>
                  <month>5</month>
                  <year>2014</year>
                </date>
                <date date-type="accepted">
                  <day>9</day>
                  <month>10</month>
                  <year>2014</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© Hersh et al.; licensee BioMed Central Ltd. 2014</copyright-statement>
                <license license-type="open-access">
                  <license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p>Chronic obstructive pulmonary disease (COPD) has been classically divided into blue bloaters and pink puffers. The utility of these clinical subtypes is unclear. However, the broader distinction between airway-predominant and emphysema-predominant COPD may be clinically relevant. The objective was to define clinical features of emphysema-predominant and non-emphysematous COPD patients.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p>Current and former smokers from the Genetic Epidemiology of COPD Study (COPDGene) had chest computed tomography (CT) scans with quantitative image analysis. Emphysema-predominant COPD was defined by low attenuation area at -950 Hounsfield Units (LAA<sub>-950</sub>) ≥10%. Non-emphysematous COPD was defined by airflow obstruction with minimal to no emphysema (LAA<sub>-950</sub> &lt; 5%).</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p>Out of 4197 COPD subjects, 1687 were classified as emphysema-predominant and 1817 as non-emphysematous; 693 had LAA<sub>-950</sub> between 5–10% and were not categorized. Subjects with emphysema-predominant COPD were older (65.6 vs 60.6 years, p &lt; 0.0001) with more severe COPD based on airflow obstruction (FEV<sub>1</sub> 44.5 vs 68.4%, p &lt; 0.0001), greater exercise limitation (6-minute walk distance 1138 vs 1331 ft, p &lt; 0.0001) and reduced quality of life (St. George’s Respiratory Questionnaire score 43 vs 31, p &lt; 0.0001). Self-reported diabetes was more frequent in non-emphysematous COPD (OR 2.13, p &lt; 0.001), which was also confirmed using a strict definition of diabetes based on medication use. The association between diabetes and non-emphysematous COPD was replicated in the ECLIPSE study.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p>Non-emphysematous COPD, defined by airflow obstruction with a paucity of emphysema on chest CT scan, is associated with an increased risk of diabetes. COPD patients without emphysema may warrant closer monitoring for diabetes, hypertension, and hyperlipidemia and vice versa.</p>
                </sec>
                <sec>
                  <title>Trial registration</title>
                  <p>Clinicaltrials.gov identifiers: COPDGene <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov/show/NCT00608764">NCT00608764</ext-link>, ECLIPSE <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov/show/NCT00292552">NCT00292552</ext-link>.</p>
                </sec>
                <sec>
                  <title>Electronic supplementary material</title>
                  <p>The online version of this article (doi:10.1186/1471-2466-14-164) contains supplementary material, which is available to authorized users.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Airway disease</kwd>
                <kwd>CT scan</kwd>
                <kwd>Diabetes mellitus</kwd>
                <kwd>Emphysema</kwd>
                <kwd>Spirometry</kwd>
              </kwd-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2014</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Background</title>
              <p>Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease, including emphysema and large and small airway disease. The most recent update from the Global Initiative for Obstructive Lung Disease (GOLD) has addressed COPD subgroups [<xref ref-type="bibr" rid="CR1">1</xref>], and there is a recognized need to better define COPD subtypes [<xref ref-type="bibr" rid="CR2">2</xref>]. Several COPD subtypes have been shown to respond to specific treatments, including long-term oxygen for hypoxemic patients [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>], lung volume reduction surgery for upper lobe predominant emphysema [<xref ref-type="bibr" rid="CR5">5</xref>], and medications including inhaled corticosteroids, azithromycin and roflumilast for frequent acute exacerbations [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR8">8</xref>].</p>
              <p>Classic COPD subtypes include the “pink puffer” (underweight, emphysema, and normal resting oxygen saturation) and the “blue bloater” (overweight, chronic bronchitis, and hypoxemia) [<xref ref-type="bibr" rid="CR9">9</xref>]. Though not appearing in the GOLD document and other management guidelines [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR10">10</xref>], these subtypes persist in textbooks [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. The pink puffer – blue bloater distinction is vaguely defined and only applies to severe COPD patients, potentially limiting its clinical utility. However, the distinction between airway-predominant and emphysema-predominant COPD, which has some parallels to the pink puffer – blue bloater classification, may still have utility [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR17">17</xref>]. Historically, determinations about the extent of emphysema and airway disease could only be made on pathological specimens; however, chest computed tomography (CT) scans provide extensive anatomic information about COPD [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. As chest CT scans are becoming more frequently used for lung cancer screening and other indications [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], these subtypes may be more easily identified in COPD patients.</p>
              <p>The Genetic Epidemiology of COPD Study (COPDGene) has enrolled over 10,000 smokers with and without COPD across the United States [<xref ref-type="bibr" rid="CR22">22</xref>]. The large sample size with extensive clinical data, including volumetric chest CT scans, allows for COPD subtyping. We aimed to create a simplified distinction between emphysema-predominant and presumed airway-predominant COPD based on the presence or absence of emphysema on chest CT scan. We hypothesized that these COPD subtypes would show associations with clinical characteristics and co-morbidities that have implications for the evaluation and management of patients with COPD. We assessed generalizability by replicating subtype associations in the Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) Study [<xref ref-type="bibr" rid="CR23">23</xref>].</p>
            </sec>
            <sec id="Sec2" sec-type="methods">
              <title>Methods</title>
              <sec id="Sec3">
                <title>Study subjects</title>
                <p>COPDGene enrolled smokers with and without COPD at 21 clinical centers throughout the United States between 2007–2011 [<xref ref-type="bibr" rid="CR22">22</xref>]. Subjects were self-classified non-Hispanic whites and non-Hispanic African Americans ages 45–80 with at least 10 pack-years of lifetime smoking. During the study visit, subjects underwent a limited physical examination, spirometry before and after inhaled bronchodilator, and a six-minute walk test to assess exercise capacity. Subjects completed questionnaires on respiratory disease, medical history and medications. The St. George’s Respiratory Questionnaire (SGRQ) measured disease-related quality of life [<xref ref-type="bibr" rid="CR24">24</xref>]. Study protocols and questionnaires are available at <ext-link ext-link-type="uri" xlink:href="http://www.copdgene.org">http://www.copdgene.org</ext-link>. The ECLIPSE study is described in the Supplementary Methods (Additional file <xref rid="MOESM1" ref-type="media">1</xref>) [<xref ref-type="bibr" rid="CR23">23</xref>]. COPDGene and ECLIPSE were approved by the institutional review boards at Partners Healthcare and all participating centers (Additional files <xref rid="MOESM2" ref-type="media">2</xref> and <xref rid="MOESM3" ref-type="media">3</xref>). Subjects provided written informed consent.</p>
              </sec>
              <sec id="Sec4">
                <title>Chest CT scans</title>
                <p>All subjects underwent a volumetric chest CT scan performed at full inspiration and at relaxed expiration. All chest CT scans were subjected to a standard quality control procedure. Quantitative image analysis was performed using 3D SLICER [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>] and VIDA Pulmonary Workstation software (Vida Diagnostics, Coralville, Iowa). Emphysema was quantified by the percent of lung voxels with attenuation ≤ -950 Hounsfield Units (HU) on inspiratory scan [<xref ref-type="bibr" rid="CR27">27</xref>]. Subjects were considered to have emphysema-predominant COPD if this value exceeded 10%, corresponding to 3 standard deviations above the mean in normal non-smokers from COPDGene [<xref ref-type="bibr" rid="CR28">28</xref>]. In contrast, non-emphysematous COPD was defined by minimal to absent emphysema, specifically &lt;5% (mean +1 SD in normal non-smokers). Airway disease was assessed by the wall area percent of segmental airways and as the square root wall area of a hypothetical airway with 10 mm internal perimeter (SRWA-Pi10) [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
              </sec>
              <sec id="Sec5">
                <title>Statistical analysis</title>
                <p>We used the COPDGene dataset version date 19-September-2012. The analysis was restricted to subjects with airflow obstruction, defined by FEV<sub>1</sub>/FVC &lt;0.7 after bronchodilator, corresponding to GOLD stages 1–4 [<xref ref-type="bibr" rid="CR1">1</xref>]. Based on expert opinion and previous COPDGene publications, we selected a set of clinical phenotypes and comorbidities to compare across the imaging subtypes (Table <xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR29">29</xref>–<xref ref-type="bibr" rid="CR37">37</xref>]. Univariate comparisons used t-tests for continuous variables and chi-squared tests for binary variables. Logistic regression models were used to adjust for covariates including age, sex, race, body mass index, current smoking status, lifetime pack-years of smoking, and severity of airflow obstruction, assessed as post-bronchodilator FEV<sub>1</sub> percent predicted. Stratified logistic regression models were adjusted for the same covariates excluding the quantitative of categorical variable that was used to define the strata (e.g. models in obese and non-obese subjects were not adjusted for BMI). Analyses were performed using R statistical software. Logistic regression analysis for diabetes in ECLIPSE is described in the Additional file <xref rid="MOESM1" ref-type="media">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p><bold>COPD characteristics and comorbidity definitions</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Characteristic or comorbidity</th><th>Definition</th><th>COPDGene reference, if applicable</th></tr></thead><tbody><tr><td>Asthma-COPD overlap</td><td>Self-report of physician diagnosis of asthma before age 40</td><td>Hardin 2011 [<xref ref-type="bibr" rid="CR29">29</xref>]</td></tr><tr><td>Hypoxemia</td><td>Resting oxygen saturation ≤88%</td><td>Kim 2011 [<xref ref-type="bibr" rid="CR30">30</xref>]</td></tr><tr><td>Frequent exacerbator</td><td>2 or more exacerbations requiring antibiotics and/or systemic steroids in the year prior to enrollment</td><td>Han 2011 [<xref ref-type="bibr" rid="CR33">33</xref>]</td></tr><tr><td>Severe, early-onset COPD</td><td>Age &lt; 55 years, FEV<sub>1</sub> &lt; 50% predicted</td><td>Foreman 2011 [<xref ref-type="bibr" rid="CR34">34</xref>]</td></tr><tr><td>Poor exercise capacity</td><td>6-minute walk distance &lt;500 feet</td><td>Rambod 2012 [<xref ref-type="bibr" rid="CR32">32</xref>]</td></tr><tr><td>Bronchodilator response</td><td>Increase in FEV<sub>1</sub> 200 ml and 12% from baseline</td><td/></tr><tr><td>Pink puffer</td><td>Emphysema &gt; 10%, BMI ≤ 20, O<sub>2</sub> sat ≥ 90%</td><td/></tr><tr><td>Blue bloater</td><td>Chronic bronchitis, BMI &gt; 25, O<sub>2</sub> sat &lt; 90%</td><td/></tr><tr><td>Chronic bronchitis</td><td>Chronic cough and phlegm for ≥3 mo/yr for at least 2 consecutive years</td><td>Kim 2011 [<xref ref-type="bibr" rid="CR31">31</xref>]</td></tr><tr><td>Chronic prednisone use</td><td>Self-report</td><td>Swift 2012 [<xref ref-type="bibr" rid="CR35">35</xref>]</td></tr><tr><td>Cardiovascular disease</td><td>Self-report of heart attack, coronary artery disease, angina, angioplasty, coronary artery bypass graft, congestive heart failure, peripheral vascular disease, transient ischemic attack or stroke</td><td>Black-Shinn 2014 [<xref ref-type="bibr" rid="CR36">36</xref>]</td></tr><tr><td>Coronary disease</td><td>Self-report of heart attack, coronary artery disease, angina, angioplasty, or coronary artery bypass graft</td><td/></tr><tr><td>Congestive heart failure</td><td>Self-report</td><td/></tr><tr><td>Peripheral vascular disease</td><td>Self-report</td><td/></tr><tr><td>Cerebrovascular disease</td><td>Self-report of transient ischemic attack or stroke</td><td/></tr><tr><td>Sleep apnea</td><td>Self-report</td><td/></tr><tr><td>Diabetes mellitus</td><td>Self-report</td><td>Kinney 2014 [<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>Metabolic syndrome</td><td>3 of 4: BMI &gt; 30 (measured), diabetes mellitus, hypertension, and high cholesterol (all self-report)</td><td/></tr><tr><td>Gastroesophageal reflux disease</td><td>Self-report</td><td/></tr><tr><td>Peptic ulcer disease</td><td>Self-report</td><td/></tr><tr><td>Osteoporosis</td><td>Self-report</td><td/></tr></tbody></table></table-wrap></p>
              </sec>
            </sec>
            <sec id="Sec6" sec-type="results">
              <title>Results</title>
              <p>COPDGene enrolled 10,300 subjects. There were 4197 current and former smokers with airflow obstruction (FEV<sub>1</sub>/FVC &lt; 0.7 on post-bronchodilator spirometry) and inspiratory chest CT scans passing quality control included in this analysis. Figure <xref rid="Fig1" ref-type="fig">1</xref> demonstrates that the classic COPD subtypes of pink puffers and blue bloaters increased in frequency in more severe COPD, yet these subjects remained infrequent even among subjects with the most severe airflow obstruction (see Table <xref rid="Tab1" ref-type="table">1</xref> for definitions). Blue bloaters were less common than pink puffers across all level of lung function impairment.<fig id="Fig1"><label>Figure 1</label><caption><p><bold>Frequencies of the “pink puffer” and “blue bloater” subtypes of COPD by severity of airflow obstruction.</bold> See Methods for definitions.</p></caption><graphic xlink:href="12890_2014_599_Fig1_HTML" id="d30e1168"/></fig></p>
              <p>Of the 4197 COPD subjects, 1687 subjects were defined as emphysema-predominant and 1817 as non-emphysematous (Table <xref rid="Tab2" ref-type="table">2</xref>, Figure <xref rid="Fig2" ref-type="fig">2</xref>). 693 subjects had emphysema values between 5–10% and could not be classified into one of the two categories (Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Table S1). Emphysema-predominant subjects had more severe COPD, based on lower lung function, reduced exercise capacity on 6-minute walk test, more severe dyspnea, and reduced quality of life (higher scores on SGRQ). Non-emphysematous subjects had greater bronchodilator responsiveness expressed as the absolute change in FEV<sub>1</sub> and as the change in FEV<sub>1</sub> as a percent of predicted FEV<sub>1</sub>, while emphysema-predominant subjects had greater change expressed as a percent of baseline FEV<sub>1</sub>. Non-emphysematous subjects had thicker airways. The characteristics of the unclassified subjects with 5–10% emphysema generally fell between the non-emphysematous and emphysema predominant subjects (Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Table S1).<table-wrap id="Tab2"><label>Table 2</label><caption><p><bold>Demographic and clinical attributes of subjects with non-emphysematous and emphysema-predominant COPD (GOLD 1–4)</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>No/minimal emphysema</th><th>Emphysema-predominant</th><th>p-value</th></tr></thead><tbody><tr><td>N</td><td align="center">1817</td><td align="center">1687</td><td align="center"/></tr><tr><td>Age</td><td align="center">60.6 (±8.8)</td><td align="center">65.6 (±7.7)</td><td align="center">&lt;0.0001</td></tr><tr><td>Male sex</td><td align="center">933 (51.3%)</td><td align="center">1000 (59.3%)</td><td align="center">&lt;0.0001</td></tr><tr><td>African American race</td><td align="center">479 (26.4%)</td><td align="center">288 (17.1%)</td><td align="center">&lt;0.0001</td></tr><tr><td>Pack-years of smoking</td><td align="center">47.3 (±24.4)</td><td align="center">55.9 (±28.1)</td><td align="center">&lt;0.0001</td></tr><tr><td>Current smoking</td><td align="center">1122 (61.8%)</td><td align="center">392 (23.2%)</td><td align="center">&lt;0.0001</td></tr><tr><td>Body Mass Index, kg/m<sup>2</sup>
</td><td align="center">29.3 (±6.3)</td><td align="center">25.9 (±5.2)</td><td align="center">&lt;0.0001</td></tr><tr><td>Forced Expiratory Volume in 1 s (FEV<sub>1</sub>), % predicted</td><td align="center">68.4 (±18.4)</td><td align="center">44.5 (±21.0)</td><td align="center">&lt;0.0001</td></tr><tr><td>GOLD Stage</td><td align="center"/><td align="center"/><td align="center"/></tr><tr><td>1</td><td align="center">487 (26.8%)</td><td align="center">121 (7.2%)</td><td align="center"/></tr><tr><td>2</td><td align="center">1025 (56.4%)</td><td align="center">453 (26.9%)</td><td align="center"/></tr><tr><td>3</td><td align="center">267 (14.7%)</td><td align="center">649 (38.5%)</td><td align="center"/></tr><tr><td>4</td><td align="center">38 (2.1%)</td><td align="center">464 (27.5%)</td><td align="center"/></tr><tr><td>FEV<sub>1</sub> / Forced Vital Capacity ratio</td><td align="center">0.61 (±0.08)</td><td align="center">0.42 (±0.12)</td><td align="center">&lt;0.0001</td></tr><tr><td>Bronchodilator response, change in FEV<sub>1</sub>, % of baseline</td><td align="center">7.2 (±11.7)</td><td align="center">9.1 (±12.6)</td><td align="center">&lt;0.0001</td></tr><tr><td>Bronchodilator response, change in FEV<sub>1</sub>, L</td><td align="center">0.11 (±0.19)</td><td align="center">0.09 (±0.13)</td><td align="center">0.001</td></tr><tr><td>Bronchodilator response, % of predicted FEV<sub>1</sub>
</td><td align="center">3.8 (±6.4)</td><td align="center">3.2 (±4.5)</td><td align="center">0.002</td></tr><tr><td>6-minute walk distance, ft.</td><td align="center">1331 (±383)</td><td align="center">1138 (±403)</td><td align="center">&lt;0.0001</td></tr><tr><td>Oxygen saturation by pulse oximetry, %</td><td align="center">95.9 (±2.8)</td><td align="center">94.0 (±3.9)</td><td align="center">&lt;0.0001</td></tr><tr><td>Modified Medical Research Council dyspnea score</td><td align="center">1.5 (±1.5)</td><td align="center">2.4 (±1.3)</td><td align="center">&lt;0.0001</td></tr><tr><td>St. George’s Respiratory Questionnaire total score</td><td align="center">30.7 (±22.9)</td><td align="center">43.0 (±20.6)</td><td align="center">&lt;0.0001</td></tr><tr><td>BODE index*</td><td align="center">1.6 (±1.7)</td><td align="center">3.6 (±2.1)</td><td align="center">&lt;0.0001</td></tr><tr><td>Emphysema at -950 Hounsfield units, %</td><td align="center">2.0 (±1.4)</td><td align="center">23.6 (±10.7)</td><td align="center">&lt;0.0001</td></tr><tr><td>Square root wall area of an airway with 10 mm internal perimeter</td><td align="center">3.71 (±0.15)</td><td align="center">3.70 (±0.13)</td><td align="center">0.001</td></tr><tr><td>Wall area % of segmental airways</td><td align="center">62.7 (±3.4)</td><td align="center">62.2 (±3.0)</td><td align="center">&lt;0.0001</td></tr></tbody></table><table-wrap-foot><p>*BODE = Body mass, airflow Obstruction, Dyspnea, Exercise capacity [<xref ref-type="bibr" rid="CR38">38</xref>].</p><p>Mean (±SD) or N (%) are shown.</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Figure 2</label><caption><p><bold>Chest CT scans from COPDGene subjects demonstrating emphysema-predominant and non-emphysematous COPD. (A)</bold> Emphysema-predominant: FEV<sub>1</sub> 55.8% predicted, 29.0% emphysema. <bold>(B)</bold> Non-emphysematous: FEV<sub>1</sub> 55.3% predicted, 4.2% emphysema.</p></caption><graphic xlink:href="12890_2014_599_Fig2_HTML" id="d30e1581"/></fig></p>
              <p>Table <xref rid="Tab3" ref-type="table">3</xref> shows the associations of the clinical characteristics and co-morbidities with the imaging subtypes. The COPD-asthma overlap group is more common in non-emphysematous COPD, as is bronchodilator responsiveness, when assessed using the American Thoracic Society/European Respiratory Society criteria [<xref ref-type="bibr" rid="CR39">39</xref>]. Underweight subjects are more common among emphysema-predominant COPD. There was no difference in the prevalence of chronic bronchitis between the two imaging subtypes. Cardiovascular disease by various definitions, though statistically different between the imaging subtypes in the multivariate regression models, was not seen more frequently in non-emphysematous subjects, with the possible exception of congestive heart failure (Table <xref rid="Tab3" ref-type="table">3</xref>). Both diabetes mellitus and the metabolic syndrome are significantly more common in non-emphysematous COPD (diabetes OR 2.13, p &lt; 0.0001; metabolic syndrome OR 1.87, p &lt; 0.0001). Using a stricter diabetes definition of self-report plus medication use (see methods in Additional file <xref rid="MOESM1" ref-type="media">1</xref>), there was a significant association with non-emphysematous COPD (OR 2.45, p &lt; 0.0001). The associations with self-reported diabetes and the metabolic syndrome were similar in analyses restricted to subjects with FEV<sub>1</sub> &lt; 80% predicted (data not shown).<table-wrap id="Tab3"><label>Table 3</label><caption><p><bold>Associations of non-emphysematous and emphysema-predominant COPD with other clinical subgroups and comorbidities</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="2">Frequency</th><th colspan="2">Logistic regression</th></tr><tr><th/><th>Non-emphysematous</th><th>Emphysema-predominant</th><th>OR (adjusted)*</th><th>p-value</th></tr></thead><tbody><tr><td>COPD/asthma overlap</td><td align="center">281 (15.5%)</td><td align="center">178 (10.6%)</td><td align="center">1.64</td><td align="center">0.0006</td></tr><tr><td>Hypoxemia</td><td align="center">44 (2.4%)</td><td align="center">159 (9.4%)</td><td align="center">0.76</td><td align="center">0.2</td></tr><tr><td>Frequent exacerbator</td><td align="center">208 (11.4%)</td><td align="center">330 (19.6%)</td><td align="center">0.88</td><td align="center">0.3</td></tr><tr><td>Severe, early-onset COPD</td><td align="center">91 (5.0%)</td><td align="center">111 (6.6%)</td><td align="center">1.07</td><td align="center">0.9</td></tr><tr><td>Poor exercise capacity</td><td align="center">51 (2.8%)</td><td align="center">119 (7.1%)</td><td align="center">0.93</td><td align="center">0.8</td></tr><tr><td>Bronchodilator response, ATS/ERS definition [<xref ref-type="bibr" rid="CR39">39</xref>]</td><td align="center">634 (34.9%)</td><td align="center">569 (33.7%)</td><td align="center">1.20</td><td align="center">0.05</td></tr><tr><td>Chronic prednisone use</td><td align="center">44 (2.4%)</td><td align="center">124 (7.4%)</td><td align="center">0.73</td><td align="center">0.2</td></tr><tr><td>Low body mass index</td><td align="center">59 (3.2%)</td><td align="center">180 (10.7%)</td><td align="center">0.39</td><td align="center">&lt;0.0001</td></tr><tr><td>Chronic bronchitis</td><td align="center">470 (25.9%)</td><td align="center">431 (25.5%)</td><td align="center">0.87</td><td align="center">0.2</td></tr><tr><td>Cardiovascular disease</td><td align="center">393 (21.6%)</td><td align="center">399 (23.7%)</td><td align="center">1.44</td><td align="center">0.0009</td></tr><tr><td>Coronary disease</td><td align="center">277 (15.2%)</td><td align="center">278 (16.5%)</td><td align="center">1.36</td><td align="center">0.01</td></tr><tr><td>Congestive heart failure</td><td align="center">91 (5.0%)</td><td align="center">59 (3.5%)</td><td align="center">3.76</td><td align="center">&lt;0.0001</td></tr><tr><td>Peripheral vascular disease</td><td align="center">58 (3.2%)</td><td align="center">53 (3.1%)</td><td align="center">1.59</td><td align="center">0.07</td></tr><tr><td>Cerebrovascular disease</td><td align="center">96 (5.3%)</td><td align="center">102 (6.0%)</td><td align="center">1.14</td><td align="center">0.5</td></tr><tr><td>Sleep apnea</td><td align="center">271 (14.9%)</td><td align="center">199 (11.8%)</td><td align="center">1.17</td><td align="center">0.3</td></tr><tr><td>Diabetes mellitus</td><td align="center">263 (14.5%)</td><td align="center">146 (8.7%)</td><td align="center">2.13</td><td align="center">&lt;0.0001</td></tr><tr><td>Metabolic syndrome</td><td align="center">360 (19.8%)</td><td align="center">173 (10.3%)</td><td align="center">1.87</td><td align="center">&lt;0.0001</td></tr><tr><td>Gastroesophageal reflux disease</td><td align="center">498 (27.4%)</td><td align="center">511 (30.3%)</td><td align="center">0.93</td><td align="center">0.5</td></tr><tr><td>Stomach ulcers</td><td align="center">147 (8.1%)</td><td align="center">183 (10.8%)</td><td align="center">0.76</td><td align="center">0.07</td></tr><tr><td>Osteoporosis</td><td align="center">278 (15.3%)</td><td align="center">372 (22.1%)</td><td align="center">0.96</td><td align="center">0.7</td></tr></tbody></table><table-wrap-foot><p>*All models were adjusted for age, sex, race, pack-years, current smoking status, BMI, and FEV<sub>1</sub>% predicted, except low body mass index regression which was adjusted for the same covariates excluding BMI. Odds ratio is for non-emphysematous compared to emphysema-predominant COPD.</p></table-wrap-foot></table-wrap></p>
              <p>To ensure that the associations with diabetes and the metabolic syndrome were not due to confounding, we performed logistic regression analyses stratified by various potential confounding factors (Table <xref rid="Tab4" ref-type="table">4</xref> and Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Table S2). The increased frequency of diabetes in non-emphysematous COPD persisted in stratified analyses of obese and non-obese subjects, current and former smokers, mild-moderate (GOLD 1–2) and severe-very severe COPD (GOLD 3–4), non-Hispanic white and African American subjects, and older and younger subjects (Table <xref rid="Tab4" ref-type="table">4</xref>). Odds ratios were similar or increased in the stratified analyses using the stricter diabetes definition of self-report plus medication (data not shown). The associations with metabolic syndrome persisted in stratified analyses (Table S2).<table-wrap id="Tab4"><label>Table 4</label><caption><p><bold>Stratified logistic regression analyses for diabetes</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variable</th><th>Stratum</th><th>Non-emphysematous</th><th>Emphysema-predominant</th><th>OR (adjusted)*</th><th>p-value</th></tr></thead><tbody><tr><td>Obesity</td><td>BMI ≤ 30</td><td align="center">89 (8.2%)</td><td align="center">90 (6.6%)</td><td align="center">1.82</td><td align="center">0.004</td></tr><tr><td/><td>BMI &gt; 30</td><td align="center">174 (23.8%)</td><td align="center">56 (17.0%)</td><td align="center">2.71</td><td align="center">&lt;0.001</td></tr><tr><td>Current smoker</td><td>No</td><td align="center">126 (18.1%)</td><td align="center">123 (9.5%)</td><td align="center">1.87</td><td align="center">&lt;0.001</td></tr><tr><td/><td>Yes</td><td align="center">137 (12.2%)</td><td align="center">23 (5.9%)</td><td align="center">2.85</td><td align="center">&lt;0.001</td></tr><tr><td>GOLD Stage</td><td>1–2</td><td align="center">191 (12.6%)</td><td align="center">47 (8.2%)</td><td align="center">1.87</td><td align="center">0.001</td></tr><tr><td/><td>3–4</td><td align="center">72 (23.6%)</td><td align="center">99 (8.9%)</td><td align="center">2.11</td><td align="center">0.001</td></tr><tr><td>Race</td><td>Non-Hispanic white</td><td align="center">185 (13.8%)</td><td align="center">113 (8.1%)</td><td align="center">2.23</td><td align="center">&lt;0.001</td></tr><tr><td/><td>African American</td><td align="center">78 (16.3%)</td><td align="center">33 (11.5%)</td><td align="center">1.96</td><td align="center">0.02</td></tr><tr><td>Age</td><td>&lt;65</td><td align="center">147 (11.8%)</td><td align="center">53 (7.1%)</td><td align="center">2.07</td><td align="center">0.001</td></tr><tr><td/><td>≥65</td><td align="center">116 (20.2%)</td><td align="center">93 (9.9%)</td><td align="center">2.16</td><td align="center">&lt;0.001</td></tr></tbody></table><table-wrap-foot><p>*Models were adjusted for age, sex, race, pack-years, current smoking status, BMI, and FEV<sub>1</sub>% predicted, excluding the variable that was used to define the strata (e.g. models in obese and non-obese subjects were not adjusted for BMI). Odds ratio is for non-emphysematous compared to emphysema-predominant COPD.</p></table-wrap-foot></table-wrap></p>
              <p>In ECLIPSE, there were 283 non-emphysema predominant and 1211 emphysema-predominant COPD subjects (Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Table S3). Similar to COPDGene, emphysema-predominant subjects had more severe airflow obstruction. Diabetes was reported by 10.6% of non-emphysematous and 8.2% of emphysema-predominant subjects. A logistic regression model replicated the association between diabetes and non-emphysema predominant COPD (OR 1.62, 1-sided p-value = 0.034).</p>
            </sec>
            <sec id="Sec7" sec-type="discussion">
              <title>Discussion</title>
              <p>In the COPDGene Study, we defined subtypes of emphysema-predominant and non-emphysematous COPD based on a distinction between high and low emphysema on chest CT scan. We found an increased prevalence of diabetes in non-emphysematous COPD subjects, which was confirmed in the ECLIPSE study. Subjects with emphysema-predominant COPD had more severe airflow obstruction, but the proportions of subjects with frequent exacerbations or exercise intolerance were similar in the two subgroups when adjusted for differences in lung function. We confirmed expected associations of asthma-COPD overlap syndrome with non-emphysematous COPD and low BMI with emphysema-predominant COPD. The classic pink puffer – blue bloater subtypes were found in low frequencies in a modern COPD population. There was no difference in the rate of chronic bronchitis across the two subtypes, highlighting another shortcoming of this classic dichotomy. The pink puffer – blue bloater distinction is unlikely to be useful and should be abandoned.</p>
              <p>The heterogeneous nature of COPD is increasingly recognized [<xref ref-type="bibr" rid="CR2">2</xref>]. Previous efforts to identify subtypes of COPD have relied on statistical approaches such as cluster analysis and have identified clusters with emphysema and airway-predominant disease [<xref ref-type="bibr" rid="CR40">40</xref>–<xref ref-type="bibr" rid="CR42">42</xref>]. Garcia-Aymerich and colleagues found a cluster of subjects with milder COPD, obesity, diabetes, and cardiovascular disease, who had less emphysema in those subjects with CT scans [<xref ref-type="bibr" rid="CR43">43</xref>]. These statistical approaches are promising, but they often require a large number of input variables and the output may be difficult to interpret. In our analysis, the simple distinction based on the presence or absence of emphysema yielded similar results and may be easier to apply clinically than the cluster-based methods.</p>
              <p>Diabetes and the metabolic syndrome are frequent comorbidities in COPD patients [<xref ref-type="bibr" rid="CR44">44</xref>–<xref ref-type="bibr" rid="CR47">47</xref>]. COPD, diabetes, and the metabolic syndrome are all related to systemic inflammation, which may explain the co-occurrence. Studies examining whether inhaled corticosteroids increase risk of diabetes have shown conflicting results [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. Regardless, any association between ICS and diabetes would not explain the high frequency of the other components of the metabolic syndrome in COPD.</p>
              <p>In a subset of COPDGene subjects, Han and colleagues examined CT features associated with COPD exacerbations [<xref ref-type="bibr" rid="CR33">33</xref>]. They found that diabetes was more frequent in subjects with airway disease, defined by airway wall measures. The current study using all COPD subjects in COPDGene extends those results, using a paucity of emphysema on CT scan as a surrogate for airway-predominant COPD. The concordant results using a simple definition of airway-predominant COPD strengthens the current findings. Inflammation in emphysema may be different from inflammation in airway disease [<xref ref-type="bibr" rid="CR50">50</xref>], explaining the variable correlations between these COPD phenotypes and other diseases associated with systemic inflammation. Analyses within well-characterized cohorts of COPD patients including biomarkers, chest CT scans and comorbidities would be required to clarify these inflammatory phenotypes.</p>
              <p>The observation that non-emphysematous COPD is associated with diabetes may have clinical implications. Current guidelines from the U.S. Preventive Services Task Force (USPTF) and other organizations recommend routine screening for hypertension and hyperlipidemia in adults [<xref ref-type="bibr" rid="CR51">51</xref>]. However, recommendations for diabetes screening vary. The USPTF recommends diabetes screening only in adults with blood pressure greater than 135/80 mmHg [<xref ref-type="bibr" rid="CR52">52</xref>]. The American Diabetes Association recommends screening all adults who are overweight and have one or more risk factors for diabetes, as well as all adults beginning at age 45 [<xref ref-type="bibr" rid="CR53">53</xref>]. One might consider adding COPD, specifically non-emphysematous COPD, to the list of diabetes risk factors. With the increasing use of chest CT scans for screening and diagnosis, physicians will increasingly be able to identify COPD patients with and without emphysema. Since patients with chronic diseases may be undertreated for other medical conditions [<xref ref-type="bibr" rid="CR54">54</xref>], our results serve as a reminder to physicians to screen for diabetes, hypertension, and lipid disorders in patients with non-emphysematous COPD. Conversely, clinicians should obtain spirometry in current and former smokers with diabetes and/or metabolic syndrome who present with respiratory symptoms.</p>
              <p>Besides a heightened awareness of disease screening in patients with non-emphysematous COPD, our findings may potentially affect treatment. For example, the phosphodiesterase-4 inhibitor roflumilast is indicated in severe COPD patients with chronic bronchitis and frequent acute exacerbations [<xref ref-type="bibr" rid="CR8">8</xref>]. Wouters et al. have shown that roflumilast improves glucose control in subjects with newly-diagnosed diabetes without COPD [<xref ref-type="bibr" rid="CR55">55</xref>]. The effect of roflumilast on both COPD and diabetes outcomes in subjects with both diseases warrants further study. Since we found that chronic bronchitis was equally frequent in both imaging subtypes, non-emphysematous COPD may define a more specific subgroup that might benefit from roflumilast than does chronic bronchitis. Other anti-inflammatory agents may also have beneficial effects in COPD subtypes. Our analysis has several limitations. We divided subjects into emphysema-predominant and non-emphysematous COPD, as a surrogate for airway-predominant COPD [<xref ref-type="bibr" rid="CR17">17</xref>]. The non-emphysematous subgroup did have large airway disease on chest CT scans. However, the major site of airflow limitation is in the small airways. Measurements of small airways (&lt;2 mm) are limited due to the spatial resolution of CT scans. Additionally, the emphysema-predominant subtype may still include substantial airway disease since we did not account for CT airway measurements when defining the subtypes. In order to be clinically-relevant, we created a simple distinction on chest CT scans which does not require complex airway measurements. The quantitative CT emphysema categories served as a surrogate for visual reading of the presence or absence of emphysema, as would be found in a clinical radiology report. Standardized radiologist readings of chest CT scans were not available in COPDGene. However, this simplified distinction proved to be generalizable to a second study population which included COPD subjects from multiple countries.</p>
              <p>In COPDGene, comorbidities were defined by subject self-report. Previous studies have shown subject report of diabetes to be reliable [<xref ref-type="bibr" rid="CR56">56</xref>–<xref ref-type="bibr" rid="CR58">58</xref>]. In addition, we confirmed our findings using a strict definition of diabetes including medication usage. However, we could not apply strict definitions of metabolic syndrome, which would require measurements of waist circumference and triglyceride, HDL, and glucose levels [<xref ref-type="bibr" rid="CR59">59</xref>]. Using more precise definitions may strengthen the associations found using self-reported data. Additionally, we used cross-sectional data, so we cannot determine the relative timing of the onset of non-emphysematous COPD and diabetes and the metabolic syndrome. Longitudinal data would be needed to address causality. COPDGene and ECLIPSE included non-Hispanic white and non-Hispanic African American subjects; it is not known whether our findings are generalizable to other racial and ethnic groups.</p>
            </sec>
            <sec id="Sec8" sec-type="conclusions">
              <title>Conclusions</title>
              <p>Despite these limitations, we were able to create an imaging-based classification of emphysema-predominant and non-emphysematous COPD. The emphysema-predominant subjects had more severe COPD, based on measures of lung function, exercise capacity and symptoms. However, the non-emphysematous COPD subjects had an increased prevalence of diabetes and the metabolic syndrome, consistent with systemic inflammation. This finding may encourage clinicians to screen for diabetes and lipid abnormalities in COPD patients, specifically those without significant emphysema. With the increase in chest CT scans being performed for other indications, such as lung cancer screening, COPD patients will be more easily able to be assigned to these imaging subtypes. Conversely, patients with diabetes or metabolic syndrome who present with respiratory symptoms should undergo spirometry to evaluate for COPD. Future studies of existing and novel anti-inflammatory agents in COPD may find better results if targeted to COPD subjects without substantial emphysema.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Electronic supplementary material</title>
              <sec id="Sec9">
                <supplementary-material content-type="local-data" id="MOESM1">
                  <media xlink:href="12890_2014_599_MOESM1_ESM.docx">
                    <caption>
                      <p>Additional file 1:
<bold>Supplementary Methods.</bold>
(DOCX 18 KB)</p>
                    </caption>
                  </media>
                </supplementary-material>
                <supplementary-material content-type="local-data" id="MOESM2">
                  <media xlink:href="12890_2014_599_MOESM2_ESM.doc">
                    <caption>
                      <p>Additional file 2:
<bold>COPDGene Institutional Review Board approvals.</bold>
(DOC 41 KB)</p>
                    </caption>
                  </media>
                </supplementary-material>
                <supplementary-material content-type="local-data" id="MOESM3">
                  <media xlink:href="12890_2014_599_MOESM3_ESM.doc">
                    <caption>
                      <p>Additional file 3:
<bold>ECLIPSE Institutional Review Board approvals.</bold>
(DOC 80 KB)</p>
                    </caption>
                  </media>
                </supplementary-material>
                <supplementary-material content-type="local-data" id="MOESM4">
                  <media xlink:href="12890_2014_599_MOESM4_ESM.docx">
                    <caption>
                      <p>Additional file 4: Table S1: Demographic and clinical attributes of subjects with non-emphysematous and emphysema-predominant COPD (GOLD 1–4), along with unclassified COPD subjects (5–10% emphysema). <bold>Table S2.</bold> Stratified logistic regression analyses in COPDGene for metabolic syndrome. <bold>Table S3.</bold> ECLIPSE subjects with non-emphysematous and emphysema-predominant COPD (GOLD 2–4). (DOCX 19 KB)</p>
                    </caption>
                  </media>
                </supplementary-material>
              </sec>
            </sec>
          </body>
          <back>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-list>
                  <def-item>
                    <term>BODE</term>
                    <def>
                      <p>Body mass index, airflow obstruction, dyspnea, and exercise capacity</p>
                    </def>
                  </def-item>
                  <def-item>
                    <term>COPD</term>
                    <def>
                      <p>Chronic obstructive pulmonary disease</p>
                    </def>
                  </def-item>
                  <def-item>
                    <term>COPDGene</term>
                    <def>
                      <p>Genetic epidemiology of COPD study</p>
                    </def>
                  </def-item>
                  <def-item>
                    <term>ECLIPSE</term>
                    <def>
                      <p>Evaluation of COPD longitudinally to identify predictive surrogate end-points</p>
                    </def>
                  </def-item>
                  <def-item>
                    <term>FEV<sub>1</sub></term>
                    <def>
                      <p>Forced expiratory volume in 1 second</p>
                    </def>
                  </def-item>
                  <def-item>
                    <term>FVC</term>
                    <def>
                      <p>Forced vital capacity</p>
                    </def>
                  </def-item>
                  <def-item>
                    <term>GOLD</term>
                    <def>
                      <p>Global initiative for chronic obstructive lung disease</p>
                    </def>
                  </def-item>
                  <def-item>
                    <term>OR</term>
                    <def>
                      <p>Odds ratio</p>
                    </def>
                  </def-item>
                  <def-item>
                    <term>SGRQ</term>
                    <def>
                      <p>St. George’s respiratory questionnaire.</p>
                    </def>
                  </def-item>
                </def-list>
              </def-list>
            </glossary>
            <fn-group>
              <fn>
                <p>
                  <bold>Competing interests</bold>
                </p>
                <p>Dr. Hersh has received lecture fees from Novartis and has been a consultant for CSL Behring. Dr. Make reports advisory board membership for Forest, AstraZeneca, Novartis, Covidien, Breathe, Merck, Sunovion, Boehringer Ingelheim, MedImmune, Ikaria, and Abbot. He has been a consultant for Astellas, Forest, and Boehringer Ingelheim. He has received research grants from AstraZeneca, GlaxoSmithKline, NABI, Boehringer Ingelheim, Sunovion, Forest, and Pfizer. He has received lecture fees from GlaxoSmithKline, Boehringer Ingelheim, Forest, and Pfizer. Dr. Lynch has been a consultant for Perceptive Imaging, Boehringer Ingelheim, Genentech, Gilead, and Intermune. He has received grants from Centocor and Siemens. Dr. Barr has received royalties from UpToDate. Dr. Cho has been a consultant for Merck. Dr. Han has been a consultant for GlaxoSmithKline, Boehringer Ingelheim, Novartis, Genentech, Medimmune, and Forest. She has received lecture fees from GlaxoSmithKline, Boehringer Ingelheim,, Pfizer, Novartis, Grifols, and Forest. She has received royalties from UpToDate. Dr. Ramsdell has received a research grant from Boehringer Ingelheim. Dr. Rennard has received grants from AstraZeneca, Biomarck, Centocor, Mpex, Nabi, Novartis, Otsuka, Boehringer Ingelheim, and Nycomed. He has been a consultant for Able Associates, Adelphi Research, APT Pharma/Britnall, Aradigm, AstraZeneca, Boehringer Ingelheim, Chiesi, CommonHealth, Consult Complete, COPDForum, Data Monitor, Decision Resource, Defined Health, Dey, Dunn Group, Easton Associates, Equinox, Gerson, GlaxoSmithKline, Infomed, KOL Connection, M. Pankove, MedaCorp, MDRX Financial, Mpex, Novartis, Oriel Therapeutics, Otsuka, Pennside, ParmaVentures, Pharmaxis, Price Waterhouse, Propagate, Pulmatrix, Reckner Associates, recruiting Resources, Roche, Schlesinger Medical, Scimed, Sudler and Hennessey, TargeGen, Theravance, UBC, Uptake Medical, VantagePoint Management, Forest, Nycomed, Pearl and Sanyko. He has served on advisory boards for Almirall, Novartis, Nycomed, and Pfizer. He has received lecture fees from AAAAI, American College of Osteopathic Physicians, Asan Medical Center, American Thoracic Society, AstraZeneca, California Society of Allergy, Convergent Health Solutions for Reviews and Trends in COPD, COPD Foundation, Creative Educational Concepts, Dey, Duke University, France Foundation, Information TV, University of Southern California, Network for Continuing Education (CHARM), Novartis, Nycomed, Otsuka, Pfizer, Sarasota Memorial Hospital, Spanish Thoracic Society, University of Washington, University of Alabama Birmingham, University of Pittsburgh, University of British Columbia, University of California Davis, and Sioux Falls VA. Dr. Sciurba has participated in consulting for GSK, AstraZeneca and Pfizer and has received research grant funding from the NIH, GSK, BI, Pfizer, Forest and Actelion. Dr. Steiner reports royalties from Elsevier Publishing and consultancy for Johnson and Johnson. Dr. van Beek is a board member of Quantitative Clinical Trials Imaging Services, Inc. He has been a consultant for Siemens Medical Systems, Synta Pharmaceuticals, and Skolkovo Foundation. He has received speaking fees from Vital Images Inc and Toshiba Medical Systems. Dr. Silverman has been a consultant for GlaxoSmithKline, AstraZeneca, and Merck. He has received research grants from GlaxoSmithKline. He has received speaking fees from GlaxoSmithKline and AstraZeneca. Dr. Calverley reports advisory board membership for AstraZeneca, Merck, Boehringer Ingelheim, GSK and Takeda. He has been a consultant for Boehringer Ingelheim, GSK and Takeda. He has received research grants from GlaxoSmithKline, Boehringer Ingelheim, and Takeda. Dr. Coxson has received consulting fees and research grants from GlaxoSmithKline and a research grant from Spiration.Dr. Tal-Singer is an employee and shareholder of GlaxoSmithKline. Drs. Bowler, Castaldi, DeMeo, Foreman, Hokanson, Lutz, Regan, Schroeder and Crapo and Mr. Harshfield report no disclosures.</p>
              </fn>
              <fn>
                <p>
                  <bold>Authors’ contributions</bold>
                </p>
                <p>Concept and design: CPH, BJM, EKS and JDC. Acquisition of data: CPH, BJM, DAL, RGB, RPB, HOC, PMAC, DLDM, MGF, MKH, JWR, EAR, SIR, JDS, FCS, RMS, EKS and JDC. Analysis and interpretation of data: CPH, BJM, DAL, PJC, MHC, HOC, BJH, JEH, SL, SIR, EJRB, JDS, EKS and JDC. Drafting of manuscript: CPH. Critical revision of manuscript: CPH, BJM, DAL, RGB, RPB, PMAC, PJC, MHC, HOC, DLDM, MGF, MKH, BJH, JEH, SL, JWR, EAR, SIR, JDS, FCS, RMS, RTS, EJRB, EKS, JDC. Funding: CPH, EKS, JDC. All authors read and approved the final manuscript.</p>
              </fn>
            </fn-group>
            <ack>
              <title>Funding</title>
              <p>Supported by U.S. National Institutes of Health grants R01HL094635 (CPH), R01NR013377 (CPH), R01HL089856 (EKS), R01HL089897 (JDC), P01HL105339 (EKS). COPDGene is also supported by the COPD Foundation through contributions made to an Industry Advisory Board comprised of AstraZeneca, Pfizer, Novartis, Boehringer-Ingelheim, Siemens, Sunovion, and GlaxoSmithKline. ECLIPSE is supported by GlaxoSmithKline. The sponsors had no role in study design; collection, analysis, and interpretation of the data; preparation of the manuscript; and decision to submit the manuscript for publication.</p>
              <p>COPDGene® Investigators - Core Units</p>
              <p><italic>Administrative Core</italic>: James Crapo, MD (PI), Edwin Silverman, MD, PhD (PI), Barry Make, MD, Elizabeth Regan, MD, Rochelle Lantz, Lori Stepp, Sandra Melanson</p>
              <p><italic>Genetic Analysis Core</italic>: Terri Beaty, PhD, Nan Laird, PhD, Christoph Lange, PhD, Michael Cho, MD, Stephanie Santorico, PhD, John Hokanson, MPH, PhD, Dawn DeMeo, MD, MPH, Nadia Hansel, MD, MPH, Craig Hersh, MD, MPH, Peter Castaldi, MD, MSc, Merry-Lynn McDonald, PhD, Jin Zhou, PhD, Manuel Mattheisen, MD, Emily Wan, MD, Megan Hardin, MD, Jacqueline Hetmanski, MS, Margaret Parker, MS, Tanda Murray, MS</p>
              <p><italic>Imaging Core</italic>: David Lynch, MB, Joyce Schroeder, MD, John Newell, Jr., MD, John Reilly, MD, Harvey Coxson, PhD, Philip Judy, PhD, Eric Hoffman, PhD, George Washko, MD, Raul San Jose Estepar, PhD, James Ross, MSc, Mustafa Al Qaisi, MD, Jordan Zach, Alex Kluiber, Jered Sieren, Tanya Mann, Deanna Richert, Alexander McKenzie, Jaleh Akhavan, Douglas Stinson</p>
              <p><italic>PFT QA Core, National Jewish Health</italic>: Robert Jensen, PhD</p>
              <p><italic>Biological Repository</italic>, <italic>Johns Hopkins University, Baltimore, MD</italic>: Homayoon Farzadegan, PhD, Stacey Meyerer, Shivam Chandan, Samantha Bragan</p>
              <p><italic>Data Coordinating Center and Biostatistics</italic>, <italic>National Jewish Health, Denver, CO</italic>: Douglas Everett, PhD, Andre Williams, PhD, Carla Wilson, MS, Anna Forssen, MS, Amber Powell, Joe Piccoli</p>
              <p><italic>Epidemiology Core</italic>, <italic>University of Colorado School of Public Health, Denver, CO</italic>: John Hokanson, MPH, PhD, Marci Sontag, PhD, Jennifer Black-Shinn, MPH, Gregory Kinney, MPH, PhDc, Sharon Lutz, MPH, PhD</p>
              <p>COPDGene® Investigators: Clinical Centers</p>
              <p><italic>Ann Arbor VA:</italic> Jeffrey Curtis, MD, Ella Kazerooni, MD</p>
              <p><italic>Baylor College of Medicine, Houston, TX</italic>: Nicola Hanania, MD, MS, Philip Alapat, MD, Venkata Bandi, MD, Kalpalatha Guntupalli, MD, Elizabeth Guy, MD, Antara Mallampalli, MD, Charles Trinh, MD, Mustafa Atik, MD, Hasan Al-Azzawi, MD, Marc Willis, DO, Susan Pinero, MD, Linda Fahr, MD, Arun Nachiappan, MD, Collin Bray, MD, L. Alexander Frigini, MD, Carlos Farinas, MD, David Katz, MD, Jose Freytes, MD, Anne Marie Marciel, MD</p>
              <p><italic>Brigham and Women’s Hospital, Boston, MA</italic>: Dawn DeMeo, MD, MPH, Craig Hersh, MD, MPH, George Washko, MD, Francine Jacobson, MD, MPH, Hiroto Hatabu, MD, PhD, Peter Clarke, MD, Ritu Gill, MD, Andetta Hunsaker, MD, Beatrice Trotman-Dickenson, MBBS, Rachna Madan, MD</p>
              <p><italic>Columbia University, New York, NY</italic>: R. Graham Barr, MD, DrPH, Byron Thomashow, MD, John Austin, MD, Belinda D’Souza, MD</p>
              <p><italic>Duke University Medical Center, Durham, NC</italic>: Neil MacIntyre, Jr., MD, Lacey Washington, MD, H Page McAdams, MD</p>
              <p><italic>Reliant Medical Group, Worcester, MA</italic>: Richard Rosiello, MD, Timothy Bresnahan, MD, Joseph Bradley, MD, Sharon Kuong, MD, Steven Meller, MD, Suzanne Roland, MD</p>
              <p><italic>Health Partners Research Foundation, Minneapolis, MN</italic>: Charlene McEvoy, MD, MPH, Joseph Tashjian, MD</p>
              <p><italic>Johns Hopkins University, Baltimore, MD</italic>: Robert Wise, MD, Nadia Hansel, MD, MPH, Robert Brown, MD, Gregory Diette, MD, Karen Horton, MD</p>
              <p><italic>Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA</italic>: Richard Casaburi, MD, PhD, Janos Porszasz, MD, PhD, Hans Fischer, MD, Matt Budoff, MD</p>
              <p><italic>Michael E. DeBakey VAMC, Houston</italic>, TX: Amir Sharafkhaneh, MD, Charles Trinh, MD, Hirani Kamal, MD, Roham Darvishi, MD, Marc Willis, DO, Susan Pinero, MD, Linda Fahr, MD, Arun Nachiappan, MD, Collin Bray, MD, L. Alexander Frigini, MD, Carlos Farinas, MD, David Katz, MD, Jose Freytes, MD, Anne Marie Marciel, MD</p>
              <p><italic>Minneapolis VA:</italic> Dennis Niewoehner, MD, Quentin Anderson, MD, Kathryn Rice, MD, Audrey Caine, MD</p>
              <p><italic>Morehouse School of Medicine, Atlanta, GA</italic>: Marilyn Foreman, MD, MS, Gloria Westney, MD, MS, Eugene Berkowitz, MD, PhD</p>
              <p><italic>National Jewish Health, Denver, CO</italic>: Russell Bowler, MD, PhD, David Lynch, MB, Joyce Schroeder, MD, Valerie Hale, MD, John Armstrong, II, MD, Debra Dyer, MD, Jonathan Chung, MD, Christian Cox, MD</p>
              <p><italic>Temple University, Philadelphia, PA</italic>: Gerard Criner, MD, Victor Kim, MD, Nathaniel Marchetti, DO, Aditi Satti, MD, A. James Mamary, MD, Robert Steiner, MD, Chandra Dass, MD, Libby Cone, MD</p>
              <p><italic>University of Alabama, Birmingham, AL:</italic> William Bailey, MD, Mark Dransfield, MD, Michael Wells, MD, Surya Bhatt, MD, Hrudaya Nath, MD, Satinder Singh, MD</p>
              <p><italic>University of California, San Diego, CA</italic>: Joe Ramsdell, MD, Paul Friedman, MD</p>
              <p><italic>University of Iowa, Iowa City, IA</italic>: Alejandro Cornellas, MD, John Newell, Jr., MD, Edwin JR van Beek, MD, PhD</p>
              <p><italic>University of Michigan, Ann Arbor, MI</italic>: Fernando Martinez, MD, MeiLan Han, MD, Ella Kazerooni, MD</p>
              <p><italic>University of Minnesota, Minneapolis, MN</italic>: Christine Wendt, MD, Tadashi Allen, MD</p>
              <p><italic>University of Pittsburgh, Pittsburgh, PA</italic>: Frank Sciurba, MD, Joel Weissfeld, MD, MPH, Carl Fuhrman, MD, Jessica Bon, MD, Danielle Hooper, MD</p>
              <p><italic>University of Texas Health Science Center at San Antonio, San Antonio, TX</italic>: Antonio Anzueto, MD, Sandra Adams, MD, Carlos Orozco, MD, Mario Ruiz, MD, Amy Mumbower, MD, Ariel Kruger, MD, Carlos Restrepo, MD, Michael Lane, MD</p>
              <p>Principal investigators and centers participating in ECLIPSE include: Bulgaria: Y. Ivanov, Pleven; K. Kostov, Sofia. Canada: J. Bourbeau, Montreal QC; M. Fitzgerald, Vancouver BC; P. Hernández, Halifax NS; K. Killian, Hamilton ON; R. Levy, Vancouver BC; F. Maltais, Montreal QC; D. O'Donnell, Kingston ON. Czech Republic: J. Krepelka, Prague. Denmark: J. Vestbo, Hvidovre. The Netherlands: E. Wouters, Horn-Maastricht. New Zealand: D. Quinn, Wellington. Norway: P. Bakke, Bergen. Slovenia: M. Kosnik, Golnik. Spain: A. Agusti, J. Sauleda, Palma de Mallorca. Ukraine: Y. Feschenko, V. Gavrisyuk, L. Yashina, Kiev; N. Monogarova, Donetsk. United Kingdom: P. Calverley, Liverpool; D. Lomas, Cambridge; W. MacNee, Edinburgh; D. Singh, Manchester; J. Wedzicha, London. United States: A. Anzueto, San Antonio, TX; S. Braman, Providence. RI; R. Casaburi, Torrance CA; B. Celli, Boston, MA; G. Giessel, Richmond, VA; M. Gotfried, Phoenix, AZ; G. Greenwald, Rancho Mirage, CA; N. Hanania, Houston, TX; D. Mahler, Lebanon, NH; B. Make, Denver, CO; S. Rennard, Omaha, NE; C. Rochester, New Haven, CT; P. Scanlon, Rochester, MN; D. Schuller, Omaha, NE; F. Sciurba, Pittsburgh, PA; A. Sharafkhaneh, Houston, TX; T. Siler, St Charles, MO; E. Silverman, Boston, MA; A. Wanner, Miami, FL; R. Wise, Baltimore, MD; R. ZuWallack, Hartford, CT.</p>
              <p>Steering Committee: H. Coxson (Canada), C. Crim (GlaxoSmithKline, USA), L. Edwards (GlaxoSmithKline, USA), D. Lomas (UK), W. MacNee (UK), E. Silverman (USA), R. Tal Singer (Co-chair, GlaxoSmithKline, USA), J. Vestbo (Co-chair, Denmark), J. Yates (GlaxoSmithKline, USA).</p>
              <p>Scientific Committee: A. Agusti (Spain), P. Calverley (UK), B. Celli (USA), C. Crim (GlaxoSmithKline, USA), B. Miller (GlaxoSmithKline, USA), W. MacNee (Chair, UK), S. Rennard (USA), R. Tal-Singer (GlaxoSmithKline, USA), E. Wouters (The Netherlands), J. Yates (GlaxoSmithKline, USA).</p>
            </ack>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vestbo</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hurd</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Agusti</surname>
                      <given-names>AG</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>PW</given-names>
                    </name>
                    <name>
                      <surname>Vogelmeier</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Anzueto</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Barnes</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Fabbri</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Martinez</surname>
                      <given-names>FJ</given-names>
                    </name>
                    <name>
                      <surname>Nishimura</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Stockley</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Sin</surname>
                      <given-names>DD</given-names>
                    </name>
                    <name>
                      <surname>Rodriguez-Roisin</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary</article-title>
                  <source>Am J Respir Crit Care Med</source>
                  <year>2012</year>
                  <volume>187</volume>
                  <issue>4</issue>
                  <fpage>347</fpage>
                  <lpage>365</lpage>
                  <pub-id pub-id-type="doi">10.1164/rccm.201204-0596PP</pub-id>
                  <?supplied-pmid 22878278?>
                  <pub-id pub-id-type="pmid">22878278</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Han</surname>
                      <given-names>MK</given-names>
                    </name>
                    <name>
                      <surname>Agusti</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Calverley</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Celli</surname>
                      <given-names>BR</given-names>
                    </name>
                    <name>
                      <surname>Criner</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Curtis</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Fabbri</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Goldin</surname>
                      <given-names>JG</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>PW</given-names>
                    </name>
                    <name>
                      <surname>Macnee</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Make</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Rabe</surname>
                      <given-names>KF</given-names>
                    </name>
                    <name>
                      <surname>Rennard</surname>
                      <given-names>SI</given-names>
                    </name>
                    <name>
                      <surname>Sciurba</surname>
                      <given-names>FC</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Vestbo</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Washko</surname>
                      <given-names>GR</given-names>
                    </name>
                    <name>
                      <surname>Wouters</surname>
                      <given-names>EF</given-names>
                    </name>
                    <name>
                      <surname>Martinez</surname>
                      <given-names>FJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Chronic obstructive pulmonary disease phenotypes: the future of COPD</article-title>
                  <source>Am J Respir Crit Care Med</source>
                  <year>2010</year>
                  <volume>182</volume>
                  <issue>5</issue>
                  <fpage>598</fpage>
                  <lpage>604</lpage>
                  <pub-id pub-id-type="doi">10.1164/rccm.200912-1843CC</pub-id>
                  <?supplied-pmid 20522794?>
                  <pub-id pub-id-type="pmid">20522794</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>Nocturnal Oxygen Therapy Trial Group</collab>
                  </person-group>
                  <article-title>Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial</article-title>
                  <source>Ann Intern Med</source>
                  <year>1980</year>
                  <volume>93</volume>
                  <issue>3</issue>
                  <fpage>391</fpage>
                  <lpage>398</lpage>
                  <pub-id pub-id-type="doi">10.7326/0003-4819-93-3-391</pub-id>
                  <pub-id pub-id-type="pmid">6776858</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>Medical Research Council Working Party</collab>
                  </person-group>
                  <article-title>Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema</article-title>
                  <source>Lancet</source>
                  <year>1981</year>
                  <volume>1</volume>
                  <issue>8222</issue>
                  <fpage>681</fpage>
                  <lpage>686</lpage>
                  <pub-id pub-id-type="pmid">6110912</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fishman</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Martinez</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Naunheim</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Piantadosi</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Wise</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Ries</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Weinmann</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Wood</surname>
                      <given-names>DE</given-names>
                    </name>
                  </person-group>
                  <article-title>A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema</article-title>
                  <source>N Engl J Med</source>
                  <year>2003</year>
                  <volume>348</volume>
                  <issue>21</issue>
                  <fpage>2059</fpage>
                  <lpage>2073</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa030287</pub-id>
                  <?supplied-pmid 12759479?>
                  <pub-id pub-id-type="pmid">12759479</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Albert</surname>
                      <given-names>RK</given-names>
                    </name>
                    <name>
                      <surname>Connett</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bailey</surname>
                      <given-names>WC</given-names>
                    </name>
                    <name>
                      <surname>Casaburi</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Cooper</surname>
                      <given-names>JA</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>Criner</surname>
                      <given-names>GJ</given-names>
                    </name>
                    <name>
                      <surname>Curtis</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Dransfield</surname>
                      <given-names>MT</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>MK</given-names>
                    </name>
                    <name>
                      <surname>Lazarus</surname>
                      <given-names>SC</given-names>
                    </name>
                    <name>
                      <surname>Make</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Marchetti</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Martinez</surname>
                      <given-names>FJ</given-names>
                    </name>
                    <name>
                      <surname>Madinger</surname>
                      <given-names>NE</given-names>
                    </name>
                    <name>
                      <surname>McEvoy</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Niewoehner</surname>
                      <given-names>DE</given-names>
                    </name>
                    <name>
                      <surname>Porsasz</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Price</surname>
                      <given-names>CS</given-names>
                    </name>
                    <name>
                      <surname>Reilly</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Scanlon</surname>
                      <given-names>PD</given-names>
                    </name>
                    <name>
                      <surname>Sciurba</surname>
                      <given-names>FC</given-names>
                    </name>
                    <name>
                      <surname>Scharf</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Washko</surname>
                      <given-names>GR</given-names>
                    </name>
                    <name>
                      <surname>Woodruff</surname>
                      <given-names>PG</given-names>
                    </name>
                    <name>
                      <surname>Anthonisen</surname>
                      <given-names>NR</given-names>
                    </name>
                    <collab>COPD Clinical Research Network</collab>
                  </person-group>
                  <article-title>Azithromycin for prevention of exacerbations of COPD</article-title>
                  <source>N Engl J Med</source>
                  <year>2011</year>
                  <volume>365</volume>
                  <issue>8</issue>
                  <fpage>689</fpage>
                  <lpage>698</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa1104623</pub-id>
                  <?supplied-pmid 21864166?>
                  <pub-id pub-id-type="pmid">21864166</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yang</surname>
                      <given-names>IA</given-names>
                    </name>
                    <name>
                      <surname>Fong</surname>
                      <given-names>KM</given-names>
                    </name>
                    <name>
                      <surname>Sim</surname>
                      <given-names>EH</given-names>
                    </name>
                    <name>
                      <surname>Black</surname>
                      <given-names>PN</given-names>
                    </name>
                    <name>
                      <surname>Lasserson</surname>
                      <given-names>TJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Inhaled corticosteroids for stable chronic obstructive pulmonary disease</article-title>
                  <source>Cochrane Database Syst Rev</source>
                  <year>2007</year>
                  <volume>2</volume>
                  <fpage>CD002991</fpage>
                  <?supplied-pmid 17443520?>
                  <pub-id pub-id-type="pmid">17443520</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Calverley</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Rabe</surname>
                      <given-names>KF</given-names>
                    </name>
                    <name>
                      <surname>Goehring</surname>
                      <given-names>UM</given-names>
                    </name>
                    <name>
                      <surname>Kristiansen</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Fabbri</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Martinez</surname>
                      <given-names>FJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials</article-title>
                  <source>Lancet</source>
                  <year>2009</year>
                  <volume>374</volume>
                  <issue>9691</issue>
                  <fpage>685</fpage>
                  <lpage>694</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0140-6736(09)61255-1</pub-id>
                  <?supplied-pmid 19716960?>
                  <pub-id pub-id-type="pmid">19716960</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dornhorst</surname>
                      <given-names>AC</given-names>
                    </name>
                  </person-group>
                  <article-title>Respiratory insufficiency</article-title>
                  <source>Lancet</source>
                  <year>1955</year>
                  <volume>268</volume>
                  <issue>6876</issue>
                  <fpage>1185</fpage>
                  <lpage>1187</lpage>
                  <?supplied-pmid 14382541?>
                  <pub-id pub-id-type="pmid">14382541</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Qaseem</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Wilt</surname>
                      <given-names>TJ</given-names>
                    </name>
                    <name>
                      <surname>Weinberger</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Hanania</surname>
                      <given-names>NA</given-names>
                    </name>
                    <name>
                      <surname>Criner</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>van der Molen</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Marciniuk</surname>
                      <given-names>DD</given-names>
                    </name>
                    <name>
                      <surname>Denberg</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Schunemann</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Wedzicha</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>MacDonald</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Shekelle</surname>
                      <given-names>P</given-names>
                    </name>
                    <collab>American College of Physicians</collab>
                  </person-group>
                  <article-title>Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society</article-title>
                  <source>Ann Intern Med</source>
                  <year>2011</year>
                  <volume>155</volume>
                  <issue>3</issue>
                  <fpage>179</fpage>
                  <lpage>191</lpage>
                  <pub-id pub-id-type="doi">10.7326/0003-4819-155-3-201108020-00008</pub-id>
                  <?supplied-pmid 21810710?>
                  <pub-id pub-id-type="pmid">21810710</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Weinberger</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Cockrill</surname>
                      <given-names>BA</given-names>
                    </name>
                    <name>
                      <surname>Mandel</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Chronic obstructive pulmonary disease</article-title>
                  <source>Principles of Pulmonary Medicine</source>
                  <year>2008</year>
                  <edition>5</edition>
                  <publisher-loc>Philadelphia</publisher-loc>
                  <publisher-name>Saunders Elsevier</publisher-name>
                  <fpage>90</fpage>
                  <lpage>109</lpage>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Niewoehner</surname>
                      <given-names>DE</given-names>
                    </name>
                  </person-group>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Goldman</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Schafer</surname>
                      <given-names>AI</given-names>
                    </name>
                  </person-group>
                  <article-title>Chronic obstructive pulmonary disease</article-title>
                  <source>Goldman’s Cecil Medicine</source>
                  <year>2012</year>
                  <edition>24</edition>
                  <publisher-loc>Philadelphia</publisher-loc>
                  <publisher-name>Elsevier Saunders</publisher-name>
                  <fpage>537</fpage>
                  <lpage>544</lpage>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Boschetto</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Miniati</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Miotto</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Braccioni</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>De Rosa</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Bononi</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Papi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Saetta</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Fabbri</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Mapp</surname>
                      <given-names>CE</given-names>
                    </name>
                  </person-group>
                  <article-title>Predominant emphysema phenotype in chronic obstructive pulmonary</article-title>
                  <source>Eur Respir J</source>
                  <year>2003</year>
                  <volume>21</volume>
                  <issue>3</issue>
                  <fpage>450</fpage>
                  <lpage>454</lpage>
                  <?supplied-pmid 12662000?>
                  <pub-id pub-id-type="pmid">12662000</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Makita</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Nasuhara</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Nagai</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Ito</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Hasegawa</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Betsuyaku</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Onodera</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Hizawa</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Nishimura</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease</article-title>
                  <source>Thorax</source>
                  <year>2007</year>
                  <volume>62</volume>
                  <issue>11</issue>
                  <fpage>932</fpage>
                  <lpage>937</lpage>
                  <pub-id pub-id-type="doi">10.1136/thx.2006.072777</pub-id>
                  <?supplied-pmid 17573447?>
                  <pub-id pub-id-type="pmid">17573447</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kitaguchi</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Fujimoto</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Kubo</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Honda</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>Characteristics of COPD phenotypes classified according to the findings of HRCT</article-title>
                  <source>Respir Med</source>
                  <year>2006</year>
                  <volume>100</volume>
                  <issue>10</issue>
                  <fpage>1742</fpage>
                  <lpage>1752</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.rmed.2006.02.003</pub-id>
                  <?supplied-pmid 16549342?>
                  <pub-id pub-id-type="pmid">16549342</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hersh</surname>
                      <given-names>CP</given-names>
                    </name>
                    <name>
                      <surname>Hansel</surname>
                      <given-names>NN</given-names>
                    </name>
                    <name>
                      <surname>Barnes</surname>
                      <given-names>KC</given-names>
                    </name>
                    <name>
                      <surname>Lomas</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Pillai</surname>
                      <given-names>SG</given-names>
                    </name>
                    <name>
                      <surname>Coxson</surname>
                      <given-names>HO</given-names>
                    </name>
                    <name>
                      <surname>Mathias</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Rafaels</surname>
                      <given-names>NM</given-names>
                    </name>
                    <name>
                      <surname>Wise</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Connett</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Klanderman</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Jacobson</surname>
                      <given-names>FL</given-names>
                    </name>
                    <name>
                      <surname>Gill</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Litonjua</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Sparrow</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Reilly</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <collab>ICGN Investigators</collab>
                  </person-group>
                  <article-title>Transforming growth factor-beta receptor-3 is associated with pulmonary emphysema</article-title>
                  <source>Am J Respir Cell Mol Biol</source>
                  <year>2009</year>
                  <volume>41</volume>
                  <issue>3</issue>
                  <fpage>324</fpage>
                  <lpage>331</lpage>
                  <pub-id pub-id-type="doi">10.1165/rcmb.2008-0427OC</pub-id>
                  <?supplied-pmid 19131638?>
                  <pub-id pub-id-type="pmid">19131638</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hersh</surname>
                      <given-names>CP</given-names>
                    </name>
                    <name>
                      <surname>Jacobson</surname>
                      <given-names>FL</given-names>
                    </name>
                    <name>
                      <surname>Gill</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                  </person-group>
                  <article-title>Computed tomography phenotypes in severe, early-onset chronic obstructive pulmonary disease</article-title>
                  <source>COPD</source>
                  <year>2007</year>
                  <volume>4</volume>
                  <issue>4</issue>
                  <fpage>331</fpage>
                  <lpage>337</lpage>
                  <pub-id pub-id-type="doi">10.1080/15412550701601274</pub-id>
                  <?supplied-pmid 18027160?>
                  <pub-id pub-id-type="pmid">18027160</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Muller</surname>
                      <given-names>NL</given-names>
                    </name>
                    <name>
                      <surname>Staples</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>RR</given-names>
                    </name>
                    <name>
                      <surname>Abboud</surname>
                      <given-names>RT</given-names>
                    </name>
                  </person-group>
                  <article-title>“Density mask”. An objective method to quantitate emphysema using computed tomography</article-title>
                  <source>Chest</source>
                  <year>1988</year>
                  <volume>94</volume>
                  <issue>4</issue>
                  <fpage>782</fpage>
                  <lpage>787</lpage>
                  <pub-id pub-id-type="doi">10.1378/chest.94.4.782</pub-id>
                  <?supplied-pmid 3168574?>
                  <pub-id pub-id-type="pmid">3168574</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nakano</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Wong</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>de Jong</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Buzatu</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Nagao</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Coxson</surname>
                      <given-names>HO</given-names>
                    </name>
                    <name>
                      <surname>Elliott</surname>
                      <given-names>WM</given-names>
                    </name>
                    <name>
                      <surname>Hogg</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Pare</surname>
                      <given-names>PD</given-names>
                    </name>
                  </person-group>
                  <article-title>The prediction of small airway dimensions using computed tomography</article-title>
                  <source>Am J Respir Crit Care Med</source>
                  <year>2005</year>
                  <volume>171</volume>
                  <issue>2</issue>
                  <fpage>142</fpage>
                  <lpage>146</lpage>
                  <pub-id pub-id-type="doi">10.1164/rccm.200407-874OC</pub-id>
                  <?supplied-pmid 15516531?>
                  <pub-id pub-id-type="pmid">15516531</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aberle</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Adams</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Berg</surname>
                      <given-names>CD</given-names>
                    </name>
                    <name>
                      <surname>Black</surname>
                      <given-names>WC</given-names>
                    </name>
                    <name>
                      <surname>Clapp</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Fagerstrom</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Gareen</surname>
                      <given-names>IF</given-names>
                    </name>
                    <name>
                      <surname>Gatsonis</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Marcus</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Sicks</surname>
                      <given-names>JD</given-names>
                    </name>
                  </person-group>
                  <article-title>Reduced lung-cancer mortality with low-dose computed tomographic screening</article-title>
                  <source>N Engl J Med</source>
                  <year>2011</year>
                  <volume>365</volume>
                  <issue>5</issue>
                  <fpage>395</fpage>
                  <lpage>409</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa1102873</pub-id>
                  <?supplied-pmid 21714641?>
                  <pub-id pub-id-type="pmid">21714641</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mets</surname>
                      <given-names>OM</given-names>
                    </name>
                    <name>
                      <surname>Buckens</surname>
                      <given-names>CF</given-names>
                    </name>
                    <name>
                      <surname>Zanen</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Isgum</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>van Ginneken</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Prokop</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Gietema</surname>
                      <given-names>HA</given-names>
                    </name>
                    <name>
                      <surname>Lammers</surname>
                      <given-names>JW</given-names>
                    </name>
                    <name>
                      <surname>Vliegenthart</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Oudkerk</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>van Klaveren</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <name>
                      <surname>de Koning</surname>
                      <given-names>HJ</given-names>
                    </name>
                    <name>
                      <surname>Mali</surname>
                      <given-names>WP</given-names>
                    </name>
                    <name>
                      <surname>de Jong</surname>
                      <given-names>PA</given-names>
                    </name>
                  </person-group>
                  <article-title>Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans</article-title>
                  <source>JAMA</source>
                  <year>2011</year>
                  <volume>306</volume>
                  <issue>16</issue>
                  <fpage>1775</fpage>
                  <lpage>1781</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2011.1531</pub-id>
                  <?supplied-pmid 22028353?>
                  <pub-id pub-id-type="pmid">22028353</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Regan</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Hokanson</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Murphy</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Make</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Lynch</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Beaty</surname>
                      <given-names>TH</given-names>
                    </name>
                    <name>
                      <surname>Curran-Everett</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Crapo</surname>
                      <given-names>JD</given-names>
                    </name>
                  </person-group>
                  <article-title>Genetic epidemiology of COPD (COPDGene) study design</article-title>
                  <source>COPD</source>
                  <year>2010</year>
                  <volume>7</volume>
                  <issue>1</issue>
                  <fpage>32</fpage>
                  <lpage>43</lpage>
                  <pub-id pub-id-type="doi">10.3109/15412550903499522</pub-id>
                  <?supplied-pmid 20214461?>
                  <pub-id pub-id-type="pmid">20214461</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vestbo</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Anderson</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Coxson</surname>
                      <given-names>HO</given-names>
                    </name>
                    <name>
                      <surname>Crim</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Dawber</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Edwards</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Hagan</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Knobil</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Lomas</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>MacNee</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Tal-Singer</surname>
                      <given-names>R</given-names>
                    </name>
                    <collab>ECLIPSE Investigators</collab>
                  </person-group>
                  <article-title>Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)</article-title>
                  <source>Eur Respir J</source>
                  <year>2008</year>
                  <volume>31</volume>
                  <issue>4</issue>
                  <fpage>869</fpage>
                  <lpage>873</lpage>
                  <pub-id pub-id-type="doi">10.1183/09031936.00111707</pub-id>
                  <?supplied-pmid 18216052?>
                  <pub-id pub-id-type="pmid">18216052</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jones</surname>
                      <given-names>PW</given-names>
                    </name>
                    <name>
                      <surname>Quirk</surname>
                      <given-names>FH</given-names>
                    </name>
                    <name>
                      <surname>Baveystock</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Littlejohns</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>A self-complete measure of health status for chronic airflow limitation. The St George’s Respiratory Questionnaire</article-title>
                  <source>Am Rev Respir Dis</source>
                  <year>1992</year>
                  <volume>145</volume>
                  <issue>6</issue>
                  <fpage>1321</fpage>
                  <lpage>1327</lpage>
                  <pub-id pub-id-type="doi">10.1164/ajrccm/145.6.1321</pub-id>
                  <?supplied-pmid 1595997?>
                  <pub-id pub-id-type="pmid">1595997</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Estepar</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Washko</surname>
                      <given-names>GG</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Reilly</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Kikinis</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Westin</surname>
                      <given-names>CF</given-names>
                    </name>
                  </person-group>
                  <article-title>Accurate airway wall estimation using phase congruency</article-title>
                  <source>Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv</source>
                  <year>2006</year>
                  <volume>9</volume>
                  <issue>Pt 2</issue>
                  <fpage>125</fpage>
                  <lpage>134</lpage>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hersh</surname>
                      <given-names>CP</given-names>
                    </name>
                    <name>
                      <surname>Washko</surname>
                      <given-names>GR</given-names>
                    </name>
                    <name>
                      <surname>Jacobson</surname>
                      <given-names>FL</given-names>
                    </name>
                    <name>
                      <surname>Gill</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Estepar</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Reilly</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                  </person-group>
                  <article-title>Interobserver variability in the determination of upper lobe-predominant emphysema</article-title>
                  <source>Chest</source>
                  <year>2007</year>
                  <volume>131</volume>
                  <issue>2</issue>
                  <fpage>424</fpage>
                  <lpage>431</lpage>
                  <pub-id pub-id-type="doi">10.1378/chest.06-1040</pub-id>
                  <?supplied-pmid 17296643?>
                  <pub-id pub-id-type="pmid">17296643</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gevenois</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>De Vuyst</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>de Maertelaer</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Zanen</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Jacobovitz</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Cosio</surname>
                      <given-names>MG</given-names>
                    </name>
                    <name>
                      <surname>Yernault</surname>
                      <given-names>JC</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparison of computed density and microscopic morphometry in pulmonary emphysema</article-title>
                  <source>Am J Respir Crit Care Med</source>
                  <year>1996</year>
                  <volume>154</volume>
                  <issue>1</issue>
                  <fpage>187</fpage>
                  <lpage>192</lpage>
                  <pub-id pub-id-type="doi">10.1164/ajrccm.154.1.8680679</pub-id>
                  <?supplied-pmid 8680679?>
                  <pub-id pub-id-type="pmid">8680679</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zach</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Newell</surname>
                      <given-names>JD</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>Schroeder</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Murphy</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Curran-Everett</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Hoffman</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Westgate</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>MK</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Crapo</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Lynch</surname>
                      <given-names>DA</given-names>
                    </name>
                    <collab>COPDGene Investigators</collab>
                  </person-group>
                  <article-title>Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults</article-title>
                  <source>Invest Radiol</source>
                  <year>2012</year>
                  <volume>47</volume>
                  <issue>10</issue>
                  <fpage>596</fpage>
                  <lpage>602</lpage>
                  <pub-id pub-id-type="doi">10.1097/RLI.0b013e318262292e</pub-id>
                  <?supplied-pmid 22836310?>
                  <pub-id pub-id-type="pmid">22836310</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hardin</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Barr</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Hansel</surname>
                      <given-names>NN</given-names>
                    </name>
                    <name>
                      <surname>Schroeder</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Make</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Crapo</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Hersh</surname>
                      <given-names>CP</given-names>
                    </name>
                    <collab>COPDGene Investigators</collab>
                  </person-group>
                  <article-title>The clinical features of the overlap between COPD and asthma</article-title>
                  <source>Respir Res</source>
                  <year>2011</year>
                  <volume>12</volume>
                  <issue>1</issue>
                  <fpage>127</fpage>
                  <pub-id pub-id-type="doi">10.1186/1465-9921-12-127</pub-id>
                  <?supplied-pmid 21951550?>
                  <pub-id pub-id-type="pmid">21951550</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>DK</given-names>
                    </name>
                    <name>
                      <surname>Jacobson</surname>
                      <given-names>FL</given-names>
                    </name>
                    <name>
                      <surname>Washko</surname>
                      <given-names>GR</given-names>
                    </name>
                    <name>
                      <surname>Casaburi</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Make</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Crapo</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Hersh</surname>
                      <given-names>CP</given-names>
                    </name>
                  </person-group>
                  <article-title>Clinical and radiographic correlates of hypoxemia and oxygen therapy in the COPDGene study</article-title>
                  <source>Respir Med</source>
                  <year>2011</year>
                  <volume>105</volume>
                  <issue>8</issue>
                  <fpage>1211</fpage>
                  <lpage>1221</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.rmed.2011.02.015</pub-id>
                  <?supplied-pmid 21396809?>
                  <pub-id pub-id-type="pmid">21396809</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>MK</given-names>
                    </name>
                    <name>
                      <surname>Vance</surname>
                      <given-names>GB</given-names>
                    </name>
                    <name>
                      <surname>Make</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Newell</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Hokanson</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Hersh</surname>
                      <given-names>CP</given-names>
                    </name>
                    <name>
                      <surname>Stinson</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Criner</surname>
                      <given-names>GJ</given-names>
                    </name>
                  </person-group>
                  <article-title>The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study</article-title>
                  <source>Chest</source>
                  <year>2011</year>
                  <volume>140</volume>
                  <issue>3</issue>
                  <fpage>626</fpage>
                  <lpage>633</lpage>
                  <pub-id pub-id-type="doi">10.1378/chest.10-2948</pub-id>
                  <?supplied-pmid 21474571?>
                  <pub-id pub-id-type="pmid">21474571</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rambod</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Porszasz</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Make</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Crapo</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Casaburi</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohort</article-title>
                  <source>Chest</source>
                  <year>2012</year>
                  <volume>141</volume>
                  <issue>4</issue>
                  <fpage>867</fpage>
                  <lpage>875</lpage>
                  <pub-id pub-id-type="doi">10.1378/chest.11-0870</pub-id>
                  <?supplied-pmid 21960696?>
                  <pub-id pub-id-type="pmid">21960696</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Han</surname>
                      <given-names>MK</given-names>
                    </name>
                    <name>
                      <surname>Kazerooni</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Lynch</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>LX</given-names>
                    </name>
                    <name>
                      <surname>Murray</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Curtis</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Criner</surname>
                      <given-names>GJ</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Bowler</surname>
                      <given-names>RP</given-names>
                    </name>
                    <name>
                      <surname>Hanania</surname>
                      <given-names>NA</given-names>
                    </name>
                    <name>
                      <surname>Anzueto</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Make</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Hokanson</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Crapo</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Martinez</surname>
                      <given-names>FJ</given-names>
                    </name>
                    <name>
                      <surname>Washko</surname>
                      <given-names>GR</given-names>
                    </name>
                    <collab>COPDGene Investigators</collab>
                  </person-group>
                  <article-title>Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes</article-title>
                  <source>Radiology</source>
                  <year>2011</year>
                  <volume>261</volume>
                  <issue>1</issue>
                  <fpage>274</fpage>
                  <lpage>282</lpage>
                  <pub-id pub-id-type="doi">10.1148/radiol.11110173</pub-id>
                  <?supplied-pmid 21788524?>
                  <pub-id pub-id-type="pmid">21788524</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Foreman</surname>
                      <given-names>MG</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Murphy</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hansel</surname>
                      <given-names>NN</given-names>
                    </name>
                    <name>
                      <surname>Make</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Hokanson</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Washko</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Regan</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Crapo</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>DeMeo</surname>
                      <given-names>DL</given-names>
                    </name>
                    <collab>COPDGene Investigators</collab>
                  </person-group>
                  <article-title>Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study</article-title>
                  <source>Am J Respir Crit Care Med</source>
                  <year>2011</year>
                  <volume>184</volume>
                  <issue>4</issue>
                  <fpage>414</fpage>
                  <lpage>420</lpage>
                  <pub-id pub-id-type="doi">10.1164/rccm.201011-1928OC</pub-id>
                  <?supplied-pmid 21562134?>
                  <pub-id pub-id-type="pmid">21562134</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Swift</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Satti</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Make</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Newell</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Steiner</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Wilson</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Murphy</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Criner</surname>
                      <given-names>GJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Demographic, physiologic and radiographic characteristics of COPD patients taking chronic systemic corticosteroids</article-title>
                  <source>COPD</source>
                  <year>2012</year>
                  <volume>9</volume>
                  <issue>1</issue>
                  <fpage>29</fpage>
                  <lpage>35</lpage>
                  <pub-id pub-id-type="doi">10.3109/15412555.2011.634454</pub-id>
                  <?supplied-pmid 22292596?>
                  <pub-id pub-id-type="pmid">22292596</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Black-Shinn</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Kinney</surname>
                      <given-names>GL</given-names>
                    </name>
                    <name>
                      <surname>Wise</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Regan</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Make</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Krantz</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Barr</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Murphy</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Lynch</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Crapo</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Hokanson</surname>
                      <given-names>JE</given-names>
                    </name>
                    <collab>COPDGene Investigators</collab>
                  </person-group>
                  <article-title>Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life</article-title>
                  <source>COPD</source>
                  <year>2014</year>
                  <volume>11</volume>
                  <issue>5</issue>
                  <fpage>546</fpage>
                  <lpage>551</lpage>
                  <pub-id pub-id-type="doi">10.3109/15412555.2014.898029</pub-id>
                  <?supplied-pmid 24831864?>
                  <pub-id pub-id-type="pmid">24831864</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kinney</surname>
                      <given-names>GL</given-names>
                    </name>
                    <name>
                      <surname>Black-Shinn</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Wan</surname>
                      <given-names>ES</given-names>
                    </name>
                    <name>
                      <surname>Make</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Regan</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Lutz</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Soler</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Crapo</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hokanson</surname>
                      <given-names>JE</given-names>
                    </name>
                  </person-group>
                  <article-title>Pulmonary function reduction in diabetes with and without chronic obstructive pulmonary disease</article-title>
                  <source>Diabetes Care</source>
                  <year>2014</year>
                  <volume>37</volume>
                  <issue>2</issue>
                  <fpage>389</fpage>
                  <lpage>395</lpage>
                  <pub-id pub-id-type="doi">10.2337/dc13-1435</pub-id>
                  <?supplied-pmid 24026562?>
                  <pub-id pub-id-type="pmid">24026562</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Celli</surname>
                      <given-names>BR</given-names>
                    </name>
                    <name>
                      <surname>Cote</surname>
                      <given-names>CG</given-names>
                    </name>
                    <name>
                      <surname>Marin</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Casanova</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Montes de Oca</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Mendez</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Pinto Plata</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Cabral</surname>
                      <given-names>HJ</given-names>
                    </name>
                  </person-group>
                  <article-title>The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease</article-title>
                  <source>N Engl J Med</source>
                  <year>2004</year>
                  <volume>350</volume>
                  <issue>10</issue>
                  <fpage>1005</fpage>
                  <lpage>1012</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa021322</pub-id>
                  <?supplied-pmid 14999112?>
                  <pub-id pub-id-type="pmid">14999112</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pellegrino</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Viegi</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Brusasco</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Crapo</surname>
                      <given-names>RO</given-names>
                    </name>
                    <name>
                      <surname>Burgos</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Casaburi</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Coates</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>van der Grinten</surname>
                      <given-names>CP</given-names>
                    </name>
                    <name>
                      <surname>Gustafsson</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Hankinson</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Jensen</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>DC</given-names>
                    </name>
                    <name>
                      <surname>MacIntyre</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>McKay</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Navajas</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Pedersen</surname>
                      <given-names>OF</given-names>
                    </name>
                    <name>
                      <surname>Wanger</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Interpretative strategies for lung function tests</article-title>
                  <source>Eur Respir J</source>
                  <year>2005</year>
                  <volume>26</volume>
                  <issue>5</issue>
                  <fpage>948</fpage>
                  <lpage>968</lpage>
                  <pub-id pub-id-type="doi">10.1183/09031936.05.00035205</pub-id>
                  <?supplied-pmid 16264058?>
                  <pub-id pub-id-type="pmid">16264058</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pistolesi</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Camiciottoli</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Paoletti</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Marmai</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Lavorini</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Meoni</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Marchesi</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Giuntini</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Identification of a predominant COPD phenotype in clinical practice</article-title>
                  <source>Respir Med</source>
                  <year>2008</year>
                  <volume>102</volume>
                  <issue>3</issue>
                  <fpage>367</fpage>
                  <lpage>376</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.rmed.2007.10.019</pub-id>
                  <?supplied-pmid 18248806?>
                  <pub-id pub-id-type="pmid">18248806</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cho</surname>
                      <given-names>MH</given-names>
                    </name>
                    <name>
                      <surname>Washko</surname>
                      <given-names>GR</given-names>
                    </name>
                    <name>
                      <surname>Hoffmann</surname>
                      <given-names>TJ</given-names>
                    </name>
                    <name>
                      <surname>Criner</surname>
                      <given-names>GJ</given-names>
                    </name>
                    <name>
                      <surname>Hoffman</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Martinez</surname>
                      <given-names>FJ</given-names>
                    </name>
                    <name>
                      <surname>Laird</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Reilly</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                  </person-group>
                  <article-title>Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation</article-title>
                  <source>Respir Res</source>
                  <year>2010</year>
                  <volume>11</volume>
                  <fpage>30</fpage>
                  <pub-id pub-id-type="doi">10.1186/1465-9921-11-30</pub-id>
                  <?supplied-pmid 20233420?>
                  <pub-id pub-id-type="pmid">20233420</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Castaldi</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Dy</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Ross</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Chang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Washko</surname>
                      <given-names>GR</given-names>
                    </name>
                    <name>
                      <surname>Curran-Everett</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lynch</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Make</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Crapo</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Bowler</surname>
                      <given-names>RP</given-names>
                    </name>
                    <name>
                      <surname>Regan</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Hokanson</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Kinney</surname>
                      <given-names>GL</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>MK</given-names>
                    </name>
                    <name>
                      <surname>Soler</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Ramsdell</surname>
                      <given-names>JW</given-names>
                    </name>
                    <name>
                      <surname>Barr</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Foreman</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>van Beek</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Casaburi</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Criner</surname>
                      <given-names>GJ</given-names>
                    </name>
                    <name>
                      <surname>Lutz</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Rennard</surname>
                      <given-names>SI</given-names>
                    </name>
                    <name>
                      <surname>Santorico</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Sciurba</surname>
                      <given-names>FC</given-names>
                    </name>
                    <name>
                      <surname>DeMeo</surname>
                      <given-names>DL</given-names>
                    </name>
                    <name>
                      <surname>Hersh</surname>
                      <given-names>CP</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Cho</surname>
                      <given-names>MH</given-names>
                    </name>
                  </person-group>
                  <article-title>Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema</article-title>
                  <source>Thorax</source>
                  <year>2014</year>
                  <volume>69</volume>
                  <issue>5</issue>
                  <fpage>415</fpage>
                  <lpage>422</lpage>
                  <pub-id pub-id-type="doi">10.1136/thoraxjnl-2013-203601</pub-id>
                  <?supplied-pmid 24563194?>
                  <pub-id pub-id-type="pmid">24563194</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Garcia-Aymerich</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Gomez</surname>
                      <given-names>FP</given-names>
                    </name>
                    <name>
                      <surname>Benet</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Farrero</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Basagana</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Gayete</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Pare</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Freixa</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Ferrer</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Ferrer</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Roca</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Galdiz</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Sauleda</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Monso</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Gea</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Barbera</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Agusti</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Anto</surname>
                      <given-names>JM</given-names>
                    </name>
                    <collab>PAC-COPD Study Group</collab>
                  </person-group>
                  <article-title>Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes</article-title>
                  <source>Thorax</source>
                  <year>2011</year>
                  <volume>66</volume>
                  <issue>5</issue>
                  <fpage>430</fpage>
                  <lpage>437</lpage>
                  <pub-id pub-id-type="doi">10.1136/thx.2010.154484</pub-id>
                  <?supplied-pmid 21177668?>
                  <pub-id pub-id-type="pmid">21177668</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Agusti</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Calverley</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Celli</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Coxson</surname>
                      <given-names>HO</given-names>
                    </name>
                    <name>
                      <surname>Edwards</surname>
                      <given-names>LD</given-names>
                    </name>
                    <name>
                      <surname>Lomas</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>MacNee</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>BE</given-names>
                    </name>
                    <name>
                      <surname>Rennard</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Tal-Singer</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Wouters</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Yates</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Vestbo</surname>
                      <given-names>J</given-names>
                    </name>
                    <collab>Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators</collab>
                  </person-group>
                  <article-title>Characterisation of COPD heterogeneity in the ECLIPSE cohort</article-title>
                  <source>Respir Res</source>
                  <year>2010</year>
                  <volume>11</volume>
                  <fpage>122</fpage>
                  <?supplied-pmid 20831787?>
                  <pub-id pub-id-type="pmid">20831787</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Martinez</surname>
                      <given-names>CH</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>MK</given-names>
                    </name>
                  </person-group>
                  <article-title>Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes</article-title>
                  <source>Med Clin North Am</source>
                  <year>2012</year>
                  <volume>96</volume>
                  <issue>4</issue>
                  <fpage>713</fpage>
                  <lpage>727</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.mcna.2012.02.007</pub-id>
                  <?supplied-pmid 22793940?>
                  <pub-id pub-id-type="pmid">22793940</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Divo</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Cote</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>de Torres</surname>
                      <given-names>JP</given-names>
                    </name>
                    <name>
                      <surname>Casanova</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Marin</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Pinto-Plata</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Zulueta</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Cabrera</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Zagaceta</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hunninghake</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Celli</surname>
                      <given-names>B</given-names>
                    </name>
                    <collab>BODE Collaborative Group</collab>
                  </person-group>
                  <article-title>Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease</article-title>
                  <source>Am J Respir Crit Care Med</source>
                  <year>2012</year>
                  <volume>186</volume>
                  <issue>2</issue>
                  <fpage>155</fpage>
                  <lpage>161</lpage>
                  <pub-id pub-id-type="doi">10.1164/rccm.201201-0034OC</pub-id>
                  <?supplied-pmid 22561964?>
                  <pub-id pub-id-type="pmid">22561964</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Clini</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Crisafulli</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Radaeli</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Malerba</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>COPD and the metabolic syndrome: an intriguing association</article-title>
                  <source>Intern Emerg Med</source>
                  <year>2013</year>
                  <volume>8</volume>
                  <issue>4</issue>
                  <fpage>283</fpage>
                  <lpage>289</lpage>
                  <pub-id pub-id-type="doi">10.1007/s11739-011-0700-x</pub-id>
                  <?supplied-pmid 21964838?>
                  <pub-id pub-id-type="pmid">21964838</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Suissa</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Kezouh</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ernst</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Inhaled corticosteroids and the risks of diabetes onset and progression</article-title>
                  <source>Am J Med</source>
                  <year>2010</year>
                  <volume>123</volume>
                  <issue>11</issue>
                  <fpage>1001</fpage>
                  <lpage>1006</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.amjmed.2010.06.019</pub-id>
                  <?supplied-pmid 20870201?>
                  <pub-id pub-id-type="pmid">20870201</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>O'Byrne</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Rennard</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Gerstein</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Radner</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Peterson</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Lindberg</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Carlsson</surname>
                      <given-names>LG</given-names>
                    </name>
                    <name>
                      <surname>Sin</surname>
                      <given-names>DD</given-names>
                    </name>
                  </person-group>
                  <article-title>Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids</article-title>
                  <source>Respir Med</source>
                  <year>2012</year>
                  <volume>106</volume>
                  <issue>11</issue>
                  <fpage>1487</fpage>
                  <lpage>1493</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.rmed.2012.07.011</pub-id>
                  <?supplied-pmid 22902134?>
                  <pub-id pub-id-type="pmid">22902134</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bon</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Leader</surname>
                      <given-names>JK</given-names>
                    </name>
                    <name>
                      <surname>Weissfeld</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Coxson</surname>
                      <given-names>HO</given-names>
                    </name>
                    <name>
                      <surname>Zheng</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Branch</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Kondragunta</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Choi</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Lokshin</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>Kaminski</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Gur</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Sciurba</surname>
                      <given-names>FC</given-names>
                    </name>
                  </person-group>
                  <article-title>The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease</article-title>
                  <source>PLoS One</source>
                  <year>2009</year>
                  <volume>4</volume>
                  <issue>8</issue>
                  <fpage>e6865</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0006865</pub-id>
                  <?supplied-pmid 19718453?>
                  <pub-id pub-id-type="pmid">19718453</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>U.S. Preventive Services Task Force</collab>
                  </person-group>
                  <article-title>Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement</article-title>
                  <source>Ann Intern Med</source>
                  <year>2007</year>
                  <volume>147</volume>
                  <issue>11</issue>
                  <fpage>783</fpage>
                  <lpage>786</lpage>
                  <pub-id pub-id-type="doi">10.7326/0003-4819-147-11-200712040-00009</pub-id>
                  <pub-id pub-id-type="pmid">18056662</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>U.S. Preventive Services Task Force</collab>
                  </person-group>
                  <article-title>Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement</article-title>
                  <source>Ann Intern Med</source>
                  <year>2008</year>
                  <volume>148</volume>
                  <issue>11</issue>
                  <fpage>846</fpage>
                  <lpage>854</lpage>
                  <pub-id pub-id-type="doi">10.7326/0003-4819-148-11-200806030-00007</pub-id>
                  <pub-id pub-id-type="pmid">18519930</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>American Diabetes Association</collab>
                  </person-group>
                  <article-title>Standards of medical care in diabetes–2012</article-title>
                  <source>Diabetes Care</source>
                  <year>2012</year>
                  <volume>35</volume>
                  <issue>Suppl 1</issue>
                  <fpage>S11</fpage>
                  <lpage>S63</lpage>
                  <pub-id pub-id-type="pmid">22187469</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Redelmeier</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Tan</surname>
                      <given-names>SH</given-names>
                    </name>
                    <name>
                      <surname>Booth</surname>
                      <given-names>GL</given-names>
                    </name>
                  </person-group>
                  <article-title>The treatment of unrelated disorders in patients with chronic medical diseases</article-title>
                  <source>N Engl J Med</source>
                  <year>1998</year>
                  <volume>338</volume>
                  <issue>21</issue>
                  <fpage>1516</fpage>
                  <lpage>1520</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJM199805213382106</pub-id>
                  <?supplied-pmid 9593791?>
                  <pub-id pub-id-type="pmid">9593791</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wouters</surname>
                      <given-names>EF</given-names>
                    </name>
                    <name>
                      <surname>Bredenbroker</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Teichmann</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Brose</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Rabe</surname>
                      <given-names>KF</given-names>
                    </name>
                    <name>
                      <surname>Fabbri</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Goke</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of the phosphodiesterase 4 inhibitor roflumilast on glucose metabolism in patients with treatment-naive, newly diagnosed type 2 diabetes mellitus</article-title>
                  <source>J Clin Endocrinol Metab</source>
                  <year>2012</year>
                  <volume>97</volume>
                  <issue>9</issue>
                  <fpage>E1720</fpage>
                  <lpage>E1725</lpage>
                  <pub-id pub-id-type="doi">10.1210/jc.2011-2886</pub-id>
                  <?supplied-pmid 22723325?>
                  <pub-id pub-id-type="pmid">22723325</pub-id>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Midthjell</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Holmen</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bjorndal</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lund-Larsen</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trondelag diabetes study</article-title>
                  <source>J Epidemiol Community Health</source>
                  <year>1992</year>
                  <volume>46</volume>
                  <issue>5</issue>
                  <fpage>537</fpage>
                  <lpage>542</lpage>
                  <pub-id pub-id-type="doi">10.1136/jech.46.5.537</pub-id>
                  <?supplied-pmid 1479327?>
                  <pub-id pub-id-type="pmid">1479327</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Beckett</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Weinstein</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Goldman</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Yu-Hsuan</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Do health interview surveys yield reliable data on chronic illness among older respondents?</article-title>
                  <source>Am J Epidemiol</source>
                  <year>2000</year>
                  <volume>151</volume>
                  <issue>3</issue>
                  <fpage>315</fpage>
                  <lpage>323</lpage>
                  <pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a010208</pub-id>
                  <?supplied-pmid 10670557?>
                  <pub-id pub-id-type="pmid">10670557</pub-id>
                </element-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oksanen</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Kivimaki</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Pentti</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Virtanen</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Klaukka</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Vahtera</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Self-report as an indicator of incident disease</article-title>
                  <source>Ann Epidemiol</source>
                  <year>2010</year>
                  <volume>20</volume>
                  <issue>7</issue>
                  <fpage>547</fpage>
                  <lpage>554</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.annepidem.2010.03.017</pub-id>
                  <?supplied-pmid 20538198?>
                  <pub-id pub-id-type="pmid">20538198</pub-id>
                </element-citation>
              </ref>
              <ref id="CR59">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grundy</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Cleeman</surname>
                      <given-names>JI</given-names>
                    </name>
                    <name>
                      <surname>Daniels</surname>
                      <given-names>SR</given-names>
                    </name>
                    <name>
                      <surname>Donato</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Eckel</surname>
                      <given-names>RH</given-names>
                    </name>
                    <name>
                      <surname>Franklin</surname>
                      <given-names>BA</given-names>
                    </name>
                    <name>
                      <surname>Gordon</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Krauss</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Savage</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>SC</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>Spertus</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Costa</surname>
                      <given-names>F</given-names>
                    </name>
                    <collab>American Heart Association</collab>
                  </person-group>
                  <article-title>Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement</article-title>
                  <source>Circulation</source>
                  <year>2005</year>
                  <volume>112</volume>
                  <issue>17</issue>
                  <fpage>2735</fpage>
                  <lpage>2752</lpage>
                  <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.169404</pub-id>
                  <?supplied-pmid 16157765?>
                  <pub-id pub-id-type="pmid">16157765</pub-id>
                </element-citation>
              </ref>
              <ref-list id="BSec1">
                <title>Pre-publication history</title>
                <ref id="CR60">
                  <mixed-citation publication-type="other">The pre-publication history for this paper can be accessed here:<ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2466/14/164/prepub">http://www.biomedcentral.com/1471-2466/14/164/prepub</ext-link></mixed-citation>
                </ref>
              </ref-list>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
